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Summary 
The cell cycle is a tightly regulated process that governs faithful replication and 
segregation of the DNA material into two daughter cells during proliferation. In order 
to ensure ordered cell cycle progression, and thus maintain genomic integrity, the 
mammalian cell cycle harbours a number of checkpoints. The activation of cell cycle 
checkpoints as well as the regulation of the DNA damage response signalling 
pathway strongly depends not only on multiple phosphorylation events, but also on 
the timely degradation of cell cycle regulators by the ubiquitin-proteasome system 
(UPS). A central component of the UPS is the AAA+-type ATPase p97, which 
recognizes ubiquitylated substrates and targets them for proteasomal degradation. 
Together with one of its co-factors, Ufd1-Npl4, p97 acts at multiple stages during cell 
cycle progression, including mitosis and S phase, thus ensuring ordered progression 
under physiological conditions and, importantly, in response to DNA damage. 
Depletion of p97Ufd1-Npl4 leads to severe defects in chromosome segregation during 
mitosis, which might not be fully explained by its mitotic function but may as well be 
caused by its interphase functions. Therefore, this work aimed at elucidating the 
relevance of p97Ufd1-Npl4 interphase functions on the manifestation of chromosome 
segregation defects in mitosis. Furthermore, we investigated the molecular basis of 
the role of p97Ufd1-Npl4 complex in modulating the G2/M checkpoint after DNA damage 
induction in human somatic cells. 
Here, we show that p97 is required to ensure robust activation of the G2/M 
checkpoint after ionizing irradiation (IR), protecting cells from entering mitosis despite 
DNA damage and thus suppressing the manifestation of chromosomal instability. 
Depletion of p97Ufd1-Npl4 in cells exposed to IR, led to an increase in segregation 
defects, which are caused by pre-mitotic errors not being repaired before entering 
mitosis, indicating a defective DNA damage response. Indeed, analysing the key 
regulators and effectors of the DNA damage response pathway, we found a delayed 
CDC25A degradation in Ufd1-Npl4 depleted cells. Moreover, using a quantitative 
FACS approach, we showed that depletion of the p97Ufd1-Npl4 complex led to an 
impaired G2/M checkpoint after irradiation with a considerable fraction of mitotic cells. 
Importantly, we showed that p97Ufd1-Npl4 ensures proper degradation of CDC25A and 
that persistent activity of the stabilized CDC25A causes a negligent G2/M checkpoint 
activation, as this phenotype was rescued by additional inhibition of CDC25 
phosphatases. Moreover, we showed that p97Ufd1-Npl4 physically interacts with the 
SCF E3 ligase F-box protein βTrCP, confirming the emerging evidence for the 
connection of p97 to multiple E3 ligase substrates. These results establish a novel 
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function of the p97Ufd1-Npl4 complex in facilitating CDC25A degradation downstream of 
ubiquitination by βTrCP and highlight a crucial aspect of p97 function for maintaining 
genome stability and integrity. 
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Zusammenfassung 
Der Zellzyklus ist ein streng regulierter Prozess, welcher die exakte Replikation und 
Segregation des genetisches Materials in zwei Tochterzellen reguliert. Um einen 
geordneten Verlauf durch den Zellzyklus und damit der Bewahrung der genomischen 
Integrität zu gewährleisten, enthält der Zellzyklus in Säugetieren sogenannte 
Kontrollpunkte. Die Aktivierung der Zellzyklus Kontrollpunkte hängt dabei nicht nur 
von zahlreichen Phosphorylierungsereignissen ab, sondern auch vom koordinierten 
Abbau der Zellzyklus regulierenden Proteine durch das Ubiquitin-Proteasom-System 
(UPS). Ein zentraler Regulator im Ubiquitin-Proteasome-System ist die AAA+-
ATPase p97, welche ubiquitinierte Substrate erkennt und sie für den proteasomalen 
Abbau überführt. Zusammen mit dem Ko-Faktor Ufd1-Npl4, reguliert p97 zahlreiche 
Ereignisse innerhalb des Zellzyklus und beeinflusst dadurch den Fortschritt des 
Zellzyklus unter physiologischen Bedingungen als auch in Reaktion auf DNA 
Schaden. Die Depletierung von p97Ufd1-Npl4 führt zu schwerwiegenden 
Segregationsdefekten in der Mitose, welche nicht vollständig durch die Funktion von 
p97 in der Mitose erklärt werden können. Vielmehr kann eine Anzahl dieser 
Segregationsdefekte aus der Funktion von p97 in verschiedenen Interphase 
Prozessen resultieren. Daher versuchten wir im Rahmen dieser Arbeit die Relevanz 
der Interphaseprozesse, welche durch p97 reguliert werden, auf die Ausprägung von 
Segregationsdefekten in der Mitose zu untersuchen.  
Darüber hinaus untersuchten wir den molekularen Mechanismus des p97Ufd1-Npl4 
Komplexes, welcher die Aktivität des G2/M Kontrollpunktes nach DNA Schaden in 
humanen, somatischen Zellen reguliert. 
In dieser Arbeit zeigen wir, dass p97 notwendig ist für die vollständige Aktivierung 
des G2/M Kontrollpunktes nach ionisierender Bestrahlung und den Eintritt in die 
Mitose in Anwesenheit von DNA Schaden und die daraus resultierende Ausprägung 
chromosomaler Instabilität verhindert. Die Depletion von p97Ufd1-Npl4 in bestrahlten 
Zellen führt zu einer Zunahme an Segregationsdefekten, die durch den Transfer von 
DNA Schäden in die Mitose entstanden sind. Durch die Analyse der 
Hauptregulatoren der DNA Schadensantwort, konnten wir einen verzögerten Abbau 
von CDC25A in p97Ufd1-Npl4 depletierten Zellen nachweisen. Darüber hinaus konnten 
wir mit quantitativen FACS Experimenten zeigen, dass p97Ufd1-Npl4 depletierte Zellen 
eine verminderte Aktivierung des DNA Schadenkontrollpunktes aufweisen und ein 
deutlicher Teil der Zellen sich trotz Bestrahlung in Mitose befindet. Ausschlaggebend 
für den Defekt in der Aktivierung des Kontrollpunktes ist dabei die Stabilisierung von 
CDC25A, da eine zusätzliche Inhibierung der CDC25 Phosphatasen den 
Kontrollpunkt vollständig wiederherstellt. Des Weiteren konnten wir zeigen, dass 
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p97Ufd1-Npl4 mit dem F-box Protein βTrCP der SCFβTrCP E3 Ligase interagiert. 
Zusammenfassend etablieren unsere Ergebnisse eine neue Funktion des p97Ufd1-Npl4 
Komplexes innerhalb der DNA Schadensantwort durch die Interaktion mit der 
SCFβTrCP E3 Ligase und der Vermittlung des Abbaus von ubiquitinierten CDC25A. 
Die vorliegende Arbeit belegt dadurch eine weitere wichtige Rolle von p97 in der 
Erhaltung der genomischen Stabilität und Integrität. 
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1 Introduction 
1.1 Mammalian cell cycle regulation 
The cell cycle consists of four phases, the G1, S, G2 and M phase, during which the 
genetic material is duplicated and segregated into two daughter cells. To ensure 
ordered progression through the cell cycle and thus maintain genomic integrity, the 
mammalian cell cycle harbours a number of checkpoints, which are activated upon 
DNA damage leading to the transient arrest in the cell cycle. The major drivers of cell 
cycle progression are the cyclin-dependent kinases (CDKs), which phosphorylate 
numerous downstream substrates. CDKs belong to the family of Serine/Threonin 
kinases that form catalytically active heterodimeric complexes with cyclins. Cyclins 
are small molecules that are expressed and degraded throughout the cell cycle in an 
oscillating manner. The different cyclins bind to their associated CDKs and activate 
them, leading to subsequent cell cycle progression by the specific CDK-cyclin 
complexes. The progression through S phase is coordinated by CDK2-cyclin E-and 
CDK2-cyclin A-mediated phosphorylation events, whereas initiation and progression 
through mitosis is regulated by the action of the CDK1-cyclin A complex and the 
CDK1-cyclin B complex, respectively (Lapenna and Giordano, 2009); (Reinhardt and 
Yaffe, 2013). The activity of the CDK-cyclin complexes and thus the cell cycle 
progression is regulated by various mechanisms, leading to the inhibition of CDK-
cyclin complexes. CDK activity is directly regulated by CDK-inhibitors (CKI ), which 
can be grouped into two families. The family of inhibitor of CDK4 (INK4)-CKIs inhibit 
the activity of CDK4 and CDK6 by binding to them and thereby prevent the 
association with their cyclins. The second family of CKIs are the CDK interacting 
protein/kinase inhibitory proteins (Cip/Kip) p21, p27 and p57, which can bind to 
cyclins and thus modulate the activity of cyclin D -, E -, A-and B-CDK complexes 
(Sherr and Roberts, 1999). In addition to CKIs, CDKs are regulated by inhibitory 
phosphorylations in their ATP-binding loop by the myelin transcription factor (MYT) 
and WEE1. Thereby CDK-cyclin complexes are held in a state where they can be 
activated rapidly by the cell division cycle (CDC) 25 dual-specific phosphatases, 
which remove the inhibitory phosphorylations and thus promote cell cycle 
progression (Besson et al., 2008; Donzelli and Draetta, 2003). By regulating the CDK 
activity through posttranslational modifications of CDK-activating- and inhibiting 
proteins, the cell can respond immediately to DNA damage induction and arrest cell 
cycle progression allowing for the repair of DNA lesions. The process of DNA 
replication and the cellular response to DNA damage are described in more detail 
below.  
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1.1.1 DNA replication 
During DNA replication the genetic material of the cell is duplicated before it is 
segregated into two daughter cells in mitosis. The exact and complete replication of 
the DNA material is essential to maintain the genomic integrity of the cell. In 
eukaryotic cells, the DNA replication is initiated by the presence of chromosomal 
elements called origins of replication. These DNA sequences direct the assembly of 
multiprotein complexes leading to the formation of two replication forks at each origin. 
The first step of DNA replication initiation is the formation of the pre-replicative 
complex (pre-RC) (Bell and Dutta, 2002). The origin recognition complex (ORC) 
binds specifically to the origins of replication and serves as platform for the formation 
of the pre-RC, consisting of the chromatin licensing and DNA replication factor 1 
(Cdt1), the cell division cycle protein 6 (Cdc6) and the mini-chromosome maintaining 
complex (MCM) 2-7 (Diffley et al., 1994). In the second step, initiation of DNA 
replication is triggered by the formation of the pre-initiation complex (pre-IC), which 
requires the phosphorylation of MCM2-7 by CDK2 – cylin E and the Dbf4 – and Drf1 
– dependent kinase (DDK) (Tanaka and Araki, 2013). Phosphorylation of MCM2 – 7 
leads to the recruitment of Cdc45 and the go-Ichi-Ni-San (GINS)-complex to the 
origins to form an active helicase complex. Further recruitment of the replication 
protein A (RPA), the primase- polymerase α, the proliferating-cell nuclear antigen 
(PCNA) and the DNA polymerases δ and ε to the origins trigger the formation of two 
bi-directional replication forks and the initiation of DNA replication. The unwinding of 
the DNA by the DNA helicase complex enables the DNA polymerase α to initiate 
DNA synthesis and the DNA polymerase δ continues the DNA replication (Bell and 
Dutta, 2002).  
To avoid re-replication of the same origin and thus preventing chromosomal 
instability, each origin just fires once in each cell cycle. The firing of origins is 
regulated either by the regulation of the availability of pre-RC components in the 
nuclei or the regulation of the activity of pre-RC components. The ubiquitination of 
the replication licensing factor Cdt1 leads to its degradation in late S phase. In 
contrast, binding of Cdt1 to geminin prevents the ubiquitination of Cdt1, but inhibits 
the DNA-binding activity of Cdt1 thereby preventing the formation of the pre-RC 
complex and subsequent initiation of DNA replication (Saxena et al., 2004).  
1.1.2 DNA damage response 
The integrity and stability of the genetic material is essential for the viability of the 
living organism. However, the DNA is not inert and is affected by a variety of DNA 
damage-inducing stimuli, including ultraviolet light (UV), ionizing radiation (IR) or 
reactive oxygen species that are a by-product of the cellular metabolism. If not 
repaired, DNA lesions can lead to mutations, which can finally result in a disease 
outcome including cancer. Therefore the sensing and repair of DNA damage during 
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the DNA damage response is essential to maintain genomic integrity and thus 
viability of the cell. To maintain genomic integrity, cells have evolved a number of 
mechanisms to detect and repair DNA damage, no matter whether this damage is 
caused by the environment or by errors during DNA replication. The DNA damage 
response is thereby tightly connected to the regulation of cell cycle progression by 
cell cycle checkpoints, which will be described in more detail in the following 
sections. 
 
Translesion synthesis 
In S phase cells are highly sensitive to DNA damage as many types of DNA damage 
lead to a block of the replication fork progression. The prolonged stalling of the 
replication fork leads to fork collapse, DNA double strand breaks (DSB) and thus 
promotes genetic instability. To prevent prolonged stalling of the replication fork, DNA 
damage tolerance (DDT) mechanisms are activated. The single DDT pathways differ 
in their potential to cause DNA mutations by either being error-prone or error-free 
mechanisms. The DDT is mediated by the translesion DNA synthesis (TLS) or DNA 
template switching (Andersen et al., 2008). The template switching is an error-free 
process that uses the newly synthesised, undamaged DNA strand of the sister 
chromatid as template to bypass the DNA lesion. In contrast, during TLS the 
specialized TLS polymerases η and κ replicate directly past the DNA lesion in an 
either error-prone or error-free fashion. TLS polymerases are low-fidelity 
polymerases, which are non-processive, lack the proof-reading ability and contain a 
larger active site that is capable of accommodating dissorted bases and base pair 
mismatches (Yang and Woodgate, 2007). The exchange of the one polymerase to 
another happens in a step-wise manner with at least two polymerase switching 
events. The first switch is the exchange of the stalled replicative polymerase to a TLS 
polymerase, which expands the TLS-patch to hide the lesion from the 3´ to 5´ 
exonuclease proofreading activity of the replicative polymerase. The final switch 
restores the replicative polymerase to the DNA template and DNA replication 
resumes. The usage of different TLS polymerases allows the specific correction of 
different kinds of DNA lesions. The polymerase η preferably repairs thymidine 
dimers, which are induced by UV light. In contrast, the polymerase κ specifically 
bypasses benzopyrene-induced guanine adducts (Zhang et al., 2000) (Ogi et al., 
2002).  
In addition to TLS and template switching, the DDT pathway is regulated by post-
translational modifications of PCNA. During the normal DNA replication process 
PCNA is sumoylated at Lys164, which inhibits homologous recombination (Papouli et 
al., 2005). In response to DNA damage, PCNA is ubiquitinated by the Rad6-Rad18 
E2-E3 ligase complex on Lys164 and thus promotes activation of TLS. Further 
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ubiquitination of PCNA leads to the promotion of the template switching DDT 
pathway (Hoege et al., 2002).  
 
DNA double strand break repair and checkpoint activation 
As mentioned above, the dissociation of the replication machinery from the stalled 
replication fork leads to collapse of the replication fork and subsequent generation of 
one-ended DNA double strand breaks (DSB). Replication-induced DSB also result 
from replication forks encountering a covalently linked topoisomerase, which is 
generated by topoisomerase inhibitors like doxorubicin (Li and Baker, 2000). In 
addition to replication stress, DSBs are induced directly by exposure of the cell to 
ionizing radiation (IR). DSBs are one of the most harmful forms of DNA damage as 
they result in chromosomal re-arrangement, depletions and chromosomal loss and 
subsequent genomic instability. DNA double strand breaks are repaired by 
nonhomologous endjoining (NHEJ) or homologous recombination repair (HR). During 
NHEJ, the DNA ligase IV directly joins the break ends using short homologous 
sequences present on the tail of the single DNA strands. If the overhangs are not 
compatible, NHEJ can lead to the formation of mutation resulting in translocations or 
telomere fusion. In contrast, during HR the homologues chromosome or the sister 
chromatid is used as a template for the repair of the DNA lesion (Moore and Haber, 
1996). In concert with the activation of the DNA damage repair, the cell cycle 
progression is arrested by the activation of cell cycle checkpoints. The activation of 
checkpoints allows the cell to repair DNA lesions before entering the next cell cycle 
phase and thus prevents genomic instability.  
The repair of DSBs starts with the binding of Mre11, Rad50 and Nbs1 (MRN)-
complex to the ends of the DSB and subsequent recruitment and activation of the 
Ataxia-telangiectasia-mutated (ATM)-kinase (Lee and Paull, 2005). ATM 
phosphorylates the histone 2AX variant (γ-H2AX) thus initiating a signalling cascade 
involving multiple phosphorylation and ubiquitination events of DNA repair proteins 
like the breast cancer 1 (BRCA1) protein and the 53-binding protein 1 (53BP1). In 
addition to ATM, also ATM- and Rad3- related (ATR) and DNA- dependent protein 
kinase catalytic subunit (DNA-PKcs) are involved in the DDR pathway (Zou and 
Elledge, 2003) (Harrison and Haber, 2006). ATM, ATR and DNA-PKcs belong to the 
family of phosphoinositide-3 kinase- related protein kinases (PIKK) and serve as 
transducers of the DNA damage signal by phosphorylating and thus activating the 
checkpoint kinases (CHK) 1 and 2 (Li and Zou, 2005). Activated CHK1 and CHK2 
phosphorylate CDC25 phosphatases finally leading to the checkpoint arrest of the 
cell (Figure 1.1).  
CDC25 are dual-specific phosphatises, which dephosphorylate CDKs on Thr14 and 
Tyr15 leading to the activation of CDKs (Pines, 1999). The mammalian genome 
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encodes three isoforms of CDC25: CDC25A, CDC25B and CDC25C, which are all 
phosphorylated by CHK1 in response to DNA damage resulting in the functional 
inactivation of CDC25. CDC25A seems to be implicated in the control of the G1 to S 
and the G2 to M transition whereas CDC25B and C appear to play a role in the 
regulation of the G2 to M transition (Rudolph, 2007). The functional inactivation of 
CDC25 is achieved by either re-localisation of the protein to the cytoplasm or 
degradation. CDC25B and CDC25C are functionally inactivated upon 
phosphorylation on Ser309/323 and Ser216, respectively, leading to 14-3-3 binding 
and nuclear exclusion (Donzelli and Draetta, 2003). In contrast, upon 
phosphorylation CDC25A is degraded by the proteasome, a process that is describe 
in detail in the following sections of this work. In addition to the CDC25 
phosphatases, CHK1 directly targets and activates WEE1, which is the kinase 
responsible for the inhibitory phosphorylation of CDK1 and CDK2 on Tyr15 thus 
promoting cell cycle arrest.  
 
 
 
Figure 1.1: Cell cycle control after DNA damage induction.  
Upon DNA damage the ATR/ATM kinases phosphorylate and activate the checkpoint kinases CHK1 
and CHK2. Activated CHK1 and CHK2 promote the DNA damage response and subsequent cell cycle 
arrest by phosphorylation of the two key regulators: the CDC25 phosphatases and the p53 
transcription factor. Upon phosphorylation p53 is active and promotes the transcription initiation of the 
CDK inhibitor p21 finally leading to cell cycle arrest. Phosphorylation of the CDC25 phosphatases 
result in their functional inactivation with subsequent cell cycle arrest, allowing the cell to repair DNA 
damage (modified from (Lapenna and Giordano, 2009)). 
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In addition to the activation of the checkpoint kinases, ATM also activates the tumour 
suppressor p53 leading to the transcription of the CDK inhibitor p21 and subsequent 
cell cycle arrest (Lobrich and Jeggo, 2007). The coordinated activation of the 
checkpoint kinases and tight regulation of cell cycle promoters and inhibitors 
mediates the controlled cell cycle arrest and recovery from DNA damage and 
subsequent progression in the cell cycle (Figure 1.1).  
 
1.2 Ubiquitin-dependent cell cycle control 
In addition to phosphorylation, ubiquitination and ubiquitin dependent proteolysis are 
important key events in the regulation of cell cycle progression. The ubiquitin 
proteasome system (UPS) plays a critical role in a wide variety of cellular processes, 
as it controls the abundance of cellular proteins. Ubiquitin is a highly conserved, 
small (8 kDa) protein that is covalently attached to substrates in a cascade manner. 
In the first step ubiquitin is linked to an ubiquitin-activating enzyme (E1) dependent 
on ATP hydrolysis. The activated ubiquitin is transferred to an ubiquitin-conjugating 
enzyme (E2), which cooperates with a E3 ubiquitin ligase that attaches ubiquitin to 
specific lysine residues of the target substrate (Hershko and Ciechanover, 1998) 
(Teixeira and Reed, 2013). The E3 ligases mediate the attachment of either only one 
ubiquitin to a specific lysine (monoubiquitination), the attachment of single ubiquitins 
to different lysines (multimonoubiquitination) or the attachment of ubiquitin-chains 
extending from a particular lysine residue (polyubiquitination). The ubiquitin can be 
linked to any of the seven lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 
and Lys63) as well as to the N-terminal methionine (Met1) (Johnson et al., 1995) 
(Peng et al., 2003) (Behrends and Harper, 2011). The different ubiquitin linkages 
create different types of ubiquitin chains and result in a wide range of molecular 
signals in the cell. Lys48-linked ubiquitin chains serve as a destruction tag for 
degradation of substrate proteins by the 26S proteasome (Baboshina and Haas, 
1996), whereas Lys63-linked chains are considered to play an essential role in 
signalling processes like the NF-κB pathway, endocytosis or DNA repair processes 
(Lamothe et al., 2007) (Kim et al., 2007) (Sobhian et al., 2007). The regulation of the 
ubiquitination state of a protein is additionally modulated by deubiquitinating enzymes 
(DUB) that hydrolyse ubiquitin-protein bonds reversing ubiquitination of target 
proteins and recycling ubiquitin (Reyes-Turcu et al., 2009).  
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Figure 1.2: Schematic illustration of the ubiquitin-proteasome system.  
In the first step ubiquitin (Ub) is linked to an ubiquitin-activating enzyme (E1) depending on ATP 
hydrolysis. The active ubiquitin is covalently linked to the target substrate by an E2 (ubiquitin-
conjugating) and E3 ligase complex. The E3 ligases belong to the HECT E3 ligase family or to the 
RING E3 ligase family. The target substrate can be linked with monoubiquitin or ubiquitin chains at 
any of the seven lysine’s found on target substrates. Depending on the type of ubiquitination, the 
biological outcome can range from protein degradation to non-proteolytical functions. (Zhang et al., 
2014) 
 
In eukaryotes two major classes of E3 ligase´s families exists: the homologous to the 
E6-AP carboxyl-terminus (HECT) and the really interesting new gene (RING)-domain 
containing E3 ligases (Rotin and Kumar, 2009). HECT E3 ligases form a transient 
and covalent linkage with ubiquitin at the conserved cysteine before they transfer 
ubiquitin to the substrate. In contrast, RING E3 ligases catalyse the transfer of 
ubiquitin from the E2 enzyme to the target substrate without direct substrate binding 
(Metzger et al., 2012). The RING-finger thereby serves as a scaffold, which brings 
the E2 enzyme and the substrate together (Ozkan et al., 2005). The mammalian 
genome encodes more than 600 potential RING E3 ligases (Li et al., 2008). These 
are further subcategorized into monomers, dimers and multi-subunit complexes, in 
which the RING-domain containing subunit and the substrate-binding domain are 
part of distinct proteins (Metzger et al., 2012). The best understood E3 ligases that 
are involved in the regulation of the cell cycle progression are the cullin-RING (CRL) 
ligases (Petroski and Deshaies, 2005) and their relative, the anaphase promoting 
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complex/cyclosome (APC/C). CRLs are characterized by their cullin-domain, which 
binds to the RING finger protein RING-box protein 1 (Rbx1). The human cullin family 
consists of seven cullins (Cul1, Cul2, Cul3, Cul4A, Cul4B, Cul5 and Cul7) and one 
more distinct member APC2 that functions in the APC/C complex. CRLs and the 
APC/C E3 ligases ubiquitinate various key cell cycle regulators like cyclins, WEE1, 
CDC25 phosphatases, p21, p27 as well as mitotic kinases Polo-like kinase 1 (PLK1), 
Aurora A and B (Carrano et al., 1999) (Koepp et al., 2001) (Strohmaier et al., 2001) 
(Sumara et al., 2007) (Beck et al., 2013). In the following sections, the cell cycle 
regulation by the APC/C complex and the CRL complexes is described in more 
detail. 
1.2.1 Anaphase promoting complex 
The APC/C complex is an important regulator of the cell cycle progression and is 
implicated in regulating processes including apoptosis, metabolism and development 
through degradation of specific substrates. The APC/C complex consist of three sub-
complexes, namely the scaffolding sub-complex, the catalytic and substrate-
recognition sub-complex and the tetra-tricopeptide repeat (TRP) arm (Foe and 
Toczyski, 2011) (Schreiber et al., 2011) (Schreiber et al., 2011). The TRP arm itself 
provides binding sites for the scaffolding unit and the co-activators Cdc20 and Cdh1 
(Vodermaier, 2004). The cell cycle regulation is controlled by the temporal 
coordination of the co-activators Cdc20 and Cdh1, which form APC/CCdc20 or 
APC/CCdh1, respectively. APC/CCdc20 regulates the metaphase to anaphase transition 
as well as mitotic exit, whereas APC/CCdh1 is active during the end of mitosis and 
early G1 phase. In G2 phase, Cdc20 is phosphorylated by CDK1 and other mitotic 
kinases promoting the interaction between APC/C and Cdc20 and thus partially 
activating APC/CCdc20 (Kramer et al., 2000) (Kraft et al., 2003). Mitotic aberrations, 
like misaligned spindle or improper attachment of kinetochores on the sister 
chromatids, inhibit the APC/CCdc20 activity due to the activation of the spindle 
assembly checkpoint (SAC). The SAC thereby negatively regulates the ability of 
Cdc20 to activate the APC/C-mediated proteolysis of downstream key regulators. 
Upon activation of the SAC, both BUBR1-BUB3 and Mad2 bind Cdc20 directly and 
inhibit its ability to activate the APC/C. The transient formation of BUBR1-BUB3-
Cdc20 and Mad2-Cdc20 complexes lead to the formation of the BUBR1-BUB3-
Mad2-Cdc20 mitotic checkpoint complex (MCC), which efficiently inhibits APC/C-
mediated degradation of downstream key regulators and arrest mitotic progression 
(Musacchio and Salmon, 2007) (Yu, 2002). After satisfaction of the SAC, the 
APC/CCdc20 complex becomes active and promotes the ubiquitin-dependent 
degradation of securin, an inhibitor of separase. Separase is a protease that cleaves 
the cohesin complex and thereby triggers sister chromatid separation (Michaelis et 
al., 1997) (Nasmyth et al., 2001). The APC/CCdc20 complex also targets cyclin B for 
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degradation, which leads to reduced activity of CDK1 and promotes mitotic exit. 
Upon exit of mitosis the inhibitory phosphorylation of Cdh1 by CDK1 is reduced 
leading to an exchange of Cdh1 with Cdc20 and thus the APC/CCdh1 complex 
becomes more active (Lukas et al., 1999) (Keck et al., 2007) (Harper et al., 2002). 
The APC/CCdh1 complex in turn promotes the degradation of CDC20, PLK1, Aurora A 
and B (Huang et al., 2001) (Lindon and Pines, 2004) (Littlepage and Ruderman, 
2002) (Stewart and Fang, 2005). 
In contrast to APC/CCdc20, the APC/CCdh1 complex is important for the cell cycle 
progression through G1 phase by sustaining low CDK1 activity mediated by the 
degradation of mitotic cyclins, CDC25A, Skp2 and CSK1 (Irniger and Nasmyth, 1997) 
(Donzelli et al., 2002) (Bashir et al., 2004). Additionally, the APC/CCdh1 complex 
promotes the ubiquitin-mediated degradation of geminin, Cdc6 and its own E2 
enzyme UBCH10 (McGarry and Kirschner, 1998) (Petersen et al., 2000) (Rape and 
Kirschner, 2004). This leads in turn to stabilization of cyclin A and inactivation of 
APC/CCdh1 leading to the timely limitation of G1 phase.  
 
1.2.2 SKP1/CUL1/F-box (SCF) protein complexes 
In addition to the APC/C complex, the CRLs are another major group of E3 ligase 
complexes regulating cell cycle progression. Cullin1 RING ligases (also known as 
SCF complex) consist of the cullin 1- scaffold unit, Rbx1 (RING)-protein, which 
recruits the E2 enzyme and the S phase kinase associated protein 1 (Skp1), which 
serves as an adaptor to bind the F-box protein, the substrate-binding unit (Figure 1.3) 
(Zheng et al., 2002). F-box proteins are named after the F-box, a 40 amino acids 
motif that was first identified in cyclin F (Fbxo1) (Bai et al., 1996). Additionally to the 
F-box, these proteins contain extra motifs that contribute to substrate binding. 
Depending on these motifs F-box proteins are classified into three subgroups: the 
WD40 containing Fbxws proteins, the leucine-rich repeats (LRR) Fbxls proteins and 
the remaining F-box proteins with other motifs like tetratrico-peptide repeats, kelch 
repeats and prolin-rich motifs called Fbxos (Cenciarelli et al., 1999) (Cardozo and 
Pagano, 2004) (Jin et al., 2004). The human genome encodes 69 F-box proteins, 
which recognize individual substrates and thereby determine the broad functional 
bandwidth of SCF ligases. A biological function has been assigned only to a few F-
box proteins. Three F-box proteins are connected to functions in the regulation of cell 
cycle progression: Skp2, Fbw7 and βTrCP. 
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Figure 1.3: Schematic representation of the SCF E3 ligase complex.  
SCF ligases contain a cullin-scaffold unit (light blue), Skp1 protein (green) and the Rbx1 (RING)-
protein (red), which recruits the E2 enzyme (yellow). Skp1 recruits the different F-box proteins (dark 
blue), which recognize specific phosphorylates sequences on target substrates triggering their 
ubiquitylation and degradation. Abbreviations: Ub- ubiquitin, P- phosphate (Teixeira and Reed, 2013) 
 
Skp2 binds substrates through its C-terminal LRR domain that requires additional 
binding of the small and highly conserved co-factor Cks1, which forms a part of the 
substrate-binding surface (Spruck et al., 2001) (Hao et al., 2005). Skp2 accumulates 
during G1 to S-phase as a consequence of APC/CCdh1 inactivation (Bashir et al., 
2004). Skp2 itself mediates the ubiquitin-dependent degradation of the CKIs p27Kip, 
p21Cip, p57Kip2 and the pocket protein p130/RB2, which leads to the increased activity 
of S phase CDK–cyclin complexes (Ganoth et al., 2001) (Bornstein et al., 2003) 
(Nakayama and Nakayama, 2006) (Frescas and Pagano, 2008) (Tedesco et al., 
2002). During replication the degradation of the origin licensing factors Orc1 and 
Cdt1 is induced by Skp2, preventing origins from becoming re-licensed and thus re-
replicated (Mendez et al., 2002) (Li et al., 2003).  
In contrast to Skp2, Fbw7 levels are constant throughout cell cycle and its 
dimerization increases the efficiency to bind to its substrates. Fbw7 mediates the 
ubiquitin-dependent degradation of cell cycle activators like cyclin E, c-myc, c-Jun 
and Notch (Welcker and Clurman, 2008) (Crusio et al., 2010). Fbw7 binds to its 
substrates phosphodegrons via a domain composed of 8 WD40 repeats (Hao et al., 
2007). The activity of Fbw7 depends not only on the phosphorylation state of its 
substrate but it is also regulated by glomulin. Glomulin is a CRL inhibitor that binds to 
Rbx1 and thereby blocks the association to the E2 enzyme Cdc34, what leads to 
accumulation of cyclin E and c-myc (Tron et al., 2012). Coupling CDK2-cyclin E 
activity to the abundance of cyclin E establishes a negative feedback loop that limits 
the maximal CDK2-cyclin E activity and defines the timely interval of the cell cycle.  
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The third F-box protein known to regulate cell cycle progression is βTrCP. Like Fbw7, 
βTrCP binds to substrate phosphodegrons via a C-terminal domain containing WD40 
repeats. βTrCP mediates the ubiquitin-dependent degradation of the cell cycle 
inhibitor WEE1, which is phosphorylated by PLK1 and CDK1 on Ser53 and Ser123, 
respectively (Watanabe et al., 2004). This positive feedback loop ensures the rapid 
activation of CDK1 and mitotic entry. The activity of PLK1 itself is regulated by the 
synergistic actions of Aurora A and Bora. Accumulation of Bora during G2 leads to 
the activation of Aurora A and thus to activation of PLK1. βTrCP also affects 
indirectly the chromosome segregation by regulating multiple aspects of the mitotic 
spindle. During mitosis, Bora regulates the localization and function of Aurora A at 
the spindle poles. The stabilization of Bora thus induces the formation of monopolar 
spindles and delays the metaphase to anaphase transition. Upon phosphorylation by 
PLK1, Bora is ubiquitinated by βTrCP and degraded (Seki et al., 2008a). In addition 
to Bora, βTrCP regulates the degradation of the repressor element 1 silencing 
transcription factor (REST) during G2 phase and ensures full activation of the SAC 
(Guardavaccaro et al., 2008). The βTrCP protein further promotes mitotic 
progression by inducing the degradation of the APC/C inhibitor Emi1 during early 
mitosis (Margottin-Goguet et al., 2003). In addition to its functions in mitosis, βTrCP 
is an important player in the regulation of the cell cycle progression in response to 
DNA damage, which is described in more detail in the last part of this section. 
In addition to the SCF complex, also other CRLs are involved in the regulation of cell 
cycle progression. The CRL3 complex controls mitotic progression through 
ubiquitination of Aurora B, which is then targeted to mitotic chromosomes to control 
their alignment (Sumara et al., 2008). CRL4 contains Cul4, Rbx1 and the DNA 
damage binding protein 1 (DDB1) domain and is implicated in the DNA replication 
and DDR. CRL4Cdt2 interacts with the ubiquitin-conjugating enzymes (UBCs) UBCH8, 
UBE2G1 and UBE2G2, to mediate the ubiquitination of various substrates (Shibata 
et al., 2011). CRL4Cdt2 mediates the degradation of the replication-licensing factor 
Cdt1 as well as degradation of p21 in normal cell cycle and after DNA damage 
induction (Hu and Xiong, 2006) (Abbas et al., 2008). In addition, CRL4 also mediates 
the ubiquitin-dependent degradation of the histone methytransferase Set8 and 
thereby regulates the H4Lys20me1 histone mono-methylation, which promotes the 
compaction of chromatin during G2 phase. After DNA damage induction, Set8 is 
targeted for proteolysis by CRL4Cdt2 in a PCNA-dependent manner (Jorgensen et al., 
2011). The availability of Cdt2 itself is regulated by another CRL, the SCFFbxo11. The 
CDK-mediated phosphorylation of Cdt2 on Thr464 inhibits binding and degradation 
by SCFFbxo11 and therefore delays cell cycle exit (Rossi et al., 2013).  
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βTrCP-mediated regulation of cell cycle checkpoints 
Besides it functions in regulation of mitotic progression, βTrCP is a component of the 
DNA damage response (DDR) and mediates the degradation of CDC25A and 
CDC25B (Kanemori et al., 2005) (Uchida et al., 2009). βTrCP1 and its ortholog 
βTrCP2 (Fbxw11) are biochemically indistinguishable and are referred as βTrCP1/2 
or βTrCP. Inhibition of βTrCP leads not only to a defective intra-S phase checkpoint 
but also to mitotic catastrophe (Busino et al., 2003). Unlike other βTrCP substrates, 
CDC25A contains a different phosphodegron 76SSESTDSG83 with three 
phosphorylated serines instead of two (DSGxxS). Interestingly, the exact mechanism 
how βTrCP binds to the CDC25A degron is not clear, as no crystal structure is yet 
available. Upon DNA damage induction, the checkpoint kinases CHK1 and CHK2 
phosphorylate CDC25A on Ser76, which serves as a priming event for further 
phosphorylation of CDC25A by other kinases (Jin et al., 2008). CHK1 activation 
additionally leads to phosphorylation of NEK11, which then in turn further 
phosphorylates CDC25A at Ser82 leading to its degradation (Melixetian et al., 2009). 
In addition to CHK1 and CHK2, several other kinases can phosphorylate CDC25A. 
The glycogensynthetase kinase 3 (GSK3)-β also phosphorylates CDC25A on 
position Ser76 after the priming of CDC25A by PLK3 (Kang et al., 2008). 
Phosphorylation of CDC25A on Ser76 by CHK1, CHK2 or GSK3β is followed by 
further phosphorylation on Ser79 and Ser82 by the casein kinase Iα (CKIα) leading to 
its ubiquitination by βTrCP and subsequent degradation (Honaker and Piwnica-
Worms, 2010). Degradation of CDC25A leads to an arrest in cell cycle progression, 
as inhibitory phosphorylations are not removed from the CDKs (Figure 1.4).  
βTrCP also mediates the MDM2-independent degradation of p53, which is 
phosphorylated on Ser362 and Ser366 by IκB kinase 2 (IκK2/IκKβ) (Xia et al., 2009). 
In addition to the functions in the DDR, βTrCP is also involved in the recovery from 
genotoxic stresses by regulation of claspin and WEE1 degradation. After DNA 
damage, the activity of PLK1 is inhibited by APC/CCdh1-mediated degradation 
(Macurek et al., 2008). During recovery the PLK1 levels increase and PLK1 is 
activated by Aurora A and Bora (Seki et al., 2008b). PLK1 and CDK1 then 
phosphorylate WEE1 leading to its βTrCP-mediated degradation (Watanabe et al., 
2004). Additionally, PLK1 also phosphorylates claspin, which is then ubiquitinated by 
βTrCP and degraded. The degradation of claspin decreases CHK1 activity leading to 
termination of the checkpoint (Peschiaroli et al., 2006) (Mamely et al., 2006) (Mailand 
et al., 2006).  
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Figure 1.4: Role of SCF ligase complex in the DNA damage response.  
Upon DNA damage ATR/ATM activate CHK1 leading to βTrCP-mediated degradation of Cdc25A, 
which inhibits CDK1 activity. In contrast, Wee1 is stabilized during the DNA damage response to 
promote arrest in the cell cycle progression. (adapted from (Bassermann et al., 2014)) 
 
1.3 The AAA+ ATPase p97 
An important component of the ubiquitin-proteasome system is the vasolin-containing 
protein (VCP)/p97, which belongs to the family of ATPases associated with various 
cellular activities (AAA+-ATPases) (Neuwald et al., 1999). p97 (also called Cdc48 in 
yeast, CDC-48 in Caenorhabitis elegans and Ter94 in flies) is an essential and highly 
abundant protein that shares 69 % sequence identity from yeast to human (Frohlich 
et al., 1991). It catalyses the hydrolysis of ATP to generate energy, which is 
transferred into mechanical forces. Accounting for more than 1 % of the total amount 
of cellular proteins, p97 is involved in a wide variety of cellular functions ranging from 
membrane fusion events and endoplasmatic reticulum-associated degradation 
(ERAD) of proteins to the regulation of cell cycle progression and the DNA damage 
response (Meyer et al., 2012) (Wolf and Stolz, 2012) (Vaz et al., 2013). Mutations of 
the p97 gene are linked to neurodegenerative diseases like amyotrophic lateral 
sclerosis (ALS) and inclusion body myopathy associated with Paget disease of bone 
and fronttemporal dementia (IBMPFD) (Johnson et al., 2010) (Watts et al., 2004). 
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1.3.1 Structure and activity 
The p97 ATPase is a homohexamer with a barrel-like structure. Thereby, each p97 
monomer consists of two conserved ATPase domains, D1 and D2, which contain a 
Walker A (P-loop) and a Walker B (DEXX box) motif for ATP binding and hydrolysis, 
respectively (Neuwald et al., 1999) (Ogura and Wilkinson, 2001). The Walker B motif 
contains a second region of homology (SRH), which is required for efficient ATP 
hydrolysis. The D1-domain is important for the formation of a stable hexamer, 
whereas the D2-domain exhibits the major ATPase activity (Wang et al., 2003a) 
(Wang et al., 2003b). The N-domain of p97 is mostly flexible and is important for 
substrate and co-factor binding. A recent study proposes a model where the N-
domain adopts either of two conformations: a flexible conformation compatible with 
ATP hydrolysis or a coplanar conformation that is inactive (Niwa et al., 2012). 
Another study identified conformational heterogeneity within two major p97 
conformations depending on the nucleotide binding state and existing simultaneously 
in solution. In conformation one, the D1-domain forms an open pore with the N-
domain in a raised position above the D1-domain. Upon nucleotide binding and 
hydrolysis the D1 ring rotates relative to the D2 ring, which may be linked to the 
remodeling of target protein complexes. In the second conformation, the D1-domain 
is tightly packed and the D2-domain is more open independent on the nucleotide 
binding state (Figure 1.5) (Yeung et al., 2014).  
 
 
 
Figure 1.5: Three-dimensional reconstructions of p97E578Q in different nucleotide states. 
Conformation 1 has a three-layered structure with the N-domain above the D1 ring in the apo state, in 
an intermediate state in ATP bound state or as a flat cap in the ADP bound state. The D1 ring is 
expanded whereas the D2 domain shows conformational changes depending on the nucleotide state. 
Conformation 2 has a two-layered architecture with the ND1 domain in the first layer and the D2 
domain in the second layer. There are only slight changes in the structure in the different nucleotide 
states. (modified from (Yeung et al., 2014)) 
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The C-terminus of p97 is highly disordered and contains a tyrosine that regulates p97 
activity in membrane fusion and nuclear translocation through its phosphorylation 
state (Lavoie et al., 2000) (Madeo et al., 1998). 
Mutations of p97 are referred to as subtle as the disease forms of p97 are “late 
onset” diseases with associated defects in intracellular protein degradation pathways 
including UPS, autophagy and endosome-lysosome fusion (Tresse et al., 2010) (Ritz 
et al., 2011). Up to date there are 20 miss-sense mutations know from clinical studies 
with patient material. The majority of the mutation is located in the N-domain and in 
the ND1-linker. The highest occurrence in patients has the mutation of the residue 
R155 (Hubbers et al., 2007). Also mutation of R155H does not lead to major changes 
in the p97 structure and does not abolish the ATPase activity of p97, it displays a 
number of alterations in the interaction of p97 and its adaptor proteins (Fernandez-
Saiz and Buchberger, 2010).  
Another p97-modification, used in our experiments to confirm p97-interaction 
partners, is the p97EQ variant. Here the conserved glutamate (E) residue in the 
Walker B motif of the D2 domain is mutated to glutamine (Q), which abolishes the 
ATP hydrolysis and leads to a dominant negative variant of p97, termed p97EQ, that 
bind but cannot release substrates (DeLaBarre and Brunger, 2005) (Pye et al., 
2006). 
1.3.2 Model of p97 function 
The p97 ATPase is an important component of the UPS that mediates the 
degradation of misfolded or damaged proteins to maintain the cellular homeostasis. 
Distinct from other classical ubiquitin-shuttling factors, p97 does not only bind to it 
substrates and the proteasome but uses the hydrolysis of ATP to structurally remodel 
or unfold its substrates to facilitate degradation by the proteasome (Yamanaka et al., 
2012). As mentioned above, a well-established function of p97 in the ubiquitin-
dependent degradation is the maintenance of protein homeostasis, as it facilitates 
the proteosomal degradation of misfolded proteins in different compartments, 
including the endoplasmatic reticulum (ER) and the outer mitochondrial membrane, 
as well as the ribosome-associated degradation of proteins (Figure 1.6). By 
facilitating the degradation of mitofusin, p97 protects the fusion of damaged and 
healthy mitochondria thereby facilitating the elimination of terminally defective 
mitochondria (Tanaka et al., 2010). In the ER-associated degradation (ERAD), p97 
bind to misfolded ubiquitinated substrates and mediates their proteosomal 
degradation. Interfering with p97 function and thus accumulation of misfolded 
proteins in the ER leads to subsequent activation of the unfolded protein stress 
response (Meyer et al., 2012) (Kothe et al., 2005). Recently, p97 was implicated in 
the ribosome-associated protein quality control and thus in the translational stress 
response. p97 thereby regulates the turnover of aberrant mRNAs as well as the 
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direct degradation of ubiquitinated ribosomal proteins by the proteasome (Brandman 
et al., 2012) (Verma et al., 2011) (Fujii et al., 2012). Besides protein quality control, 
p97 is implicated in the regulation of signalling processes by the procession of 
cytosolic proteins, including the degradation the NFκB inhibitor IκBα and the 
degradation of HIFα, which leads to the activation of NFκB and down-regulation of 
the hypoxic response, respectively (Li et al, 2014, Alexandru et al, 2008). 
Furthermore, p97 is connected to an emerging number of chromatin-associated 
functions, which governs the timely degradation of cell cycle regulators and thus 
ensures ordered cell cycle progression (Vaz et al., 2013). The multiple aspects of 
p97 in the cell cycle regulation will be described in more detail in the following 
sections.  
Additionally to the proteasome-dependent degradation of proteins, p97 is also 
implicated in the lysosomal degradation, as it mediates the sorting of cargo proteins 
through the endosomal pathway as well as through autophagy, although the exact 
mechanism of p97 function in autophagy remains not fully understood (Ritz et al., 
2011) (Kirchner et al., 2013) (Meyer et al., 2012).  
In addition to protein quality control-related protein degradation, specific p97 
complexes associate with mono-ubiquitinated substrates and facilitate proteasome-
independent membrane trafficking events, including Golgi reassembly by promoting 
membrane-protein segregation (Meyer et al., 2002) (Kondo et al., 1997). 
Furthermore, p97 is also implicated in non-degradative processes, promoting the 
extractions of transcription factor precursors from membranes, leading to their 
subsequent activation.  
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Figure 1.6 Cellular functions of p97 in interphase cells.  
The best understood function of p97 is its function in ER-associated degradation (ERAD). In addition 
p97 is involved in the handling of protein aggregates, in the degradation of mitochondrial outer-
membrane proteins and in the chromatin-associated degradation of proteins. p97 also facilitates the 
proteasome-independent degradation of proteins via the lysosomal pathway by mediating the 
endosomal sorting in endocytosis and the regulation of autophagy. Target substrates are coloured in 
green, proteasome in violet and ubiquitin in orange. (modified from (Meyer et al., 2012)) 
1.3.3 p97 adaptor protein system 
As p97 is involved in a wide range of cellular processes, its activity needs to be 
specified for the distinct functions. Therefore p97 interacts with a large number of 
adaptor proteins, which contain different p97-binding domains or motif (Figure 1.7). 
The various p97 adaptor proteins are believed to bind to p97 in a hierarchical 
manner, meaning that p97 forms core complexes with mutually exclusive major co-
factors including Ufd1-Npl4, p47 and UBXD1 (Meyer et al., 2012). The binding of 
additional co-factors modulates the localization of p97 or acquires additional 
enzymatic activity and thereby mediates specific p97 functions. Interestingly, p97 
binds to ubiquitin directly in vitro, however it is believed that in vivo p97requires the 
binding of substrate recruiting co-factors to obtain optimal activity (Rape et al., 2001). 
Since p97 acts on ubiquitinated substrates, the substrate recruiting factors contain 
ubiquitin-binding domains to mediate a more stable enzyme-substrate complex 
formation (Meyer et al., 2002). Some adaptor proteins like VIMP and Derlin-1 do not 
bind to ubiquitin but are still considered to be substrate-recruiting factors as they 
tether p97 to the ER membrane at the sites of ERAD and thereby allow a more 
efficient degradation of ubiquitinated substrates. Two distinct models describe the 
	  26	  
	  
sequential p97-substrate complex formation. In the first model, the complex 
assembly starts with the binding of an adaptor protein to the substrate. The adaptor-
substrate complex recruits p97. Such a mechanism was shown for UBXD7 and 
SAKS1, where the p97 activity is regulated by the availability of the substrate 
(Madsen et al., 2009). In the second model of p97-substrate complex formation, the 
binding of the adaptor protein to p97 creates a complex that is able to bind to 
ubiquitinated substrates. After the formation of a p97-substrate complex, p97 can 
also bind additional substrate-processing co-factors. Substrate-processing co-factors 
often equip p97 with additional enzymatic activity or inhibit the p97 activity. Some 
substrate-processing factors display DUB activity preventing p97 substrates from 
degradation. The yeast enzyme OTU1 removes ubiquitin chains from Ufd1-Npl4 
recruited p97 substrates and thereby prevents their degradation (Rumpf and Jentsch, 
2006). In addition to preventing ubiquitinated substrates from proteasomal 
degradation, DUBs can also promote degradation of substrates by cutting 
polyubiquitin branches into ubiquitin chains that can be recognized by the 
proteasome.  
 
 
 
Figure 1.7: p97 and p97 co-factor domain structure.  
The p97 monomer consists of a N-domain and the two ATPase-domains D1 and D2. The D1-domain 
is believed to be important for ATP binding whereas the D2 domain is mostly important for ATP 
hydrolysis. p97 co-factors bind to the N-domain of p97 via their UBX, UBX-L domains or via short 
binding motifs like the BS1, VBM and VIM motif. PUB or PUL domains bind to the C-terminus of p97. 
With the ubiquitin-binding domains like UBA, NZF in Npl4 and PFU in Ufd3/PLAA p97 adaptors bind to 
ubiquitin. UAS: ubiquitin-associating, UT3: Ufd1 truncation 3 domain, SEP: Shp1-eyc-p47 domain. The 
OTU and Josephin domains have deubiquitinating activity. (modified from (Meyer et al., 2012)) 
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The majority of p97 co-factors bind to the N domain of p97 by interacting with either 
the UBX domain or the UBX-like (UBX-L) domain. In addition, adaptor proteins bind 
p97 via different binding motifs like the SHP box (also called Binding Site 1), the VCP 
binding motif (VBM) or the VCP interacting motif (VIM) (Buchberger 2010; Kloppsteck 
et al. 2012; Meyer et al. 2002; H. Meyer 2012). Some co-factors bind to the C-
terminal tail of p97 by interacting with the PUB or PUL domains (Figure 1.7) (Madsen 
et al. 2009). Below, the p97 co-factors Ufd1-Npl4, DVC1 and UBXD7 are described 
in more detail. 
 
Ufd1-Npl4 
As mentioned above the p97 co-factors p47 and Ufd1-Npl4 bind to the N domain of 
p97 in a mutually exclusive manner (Bruderer et al., 2004) (Meyer et al., 2000). The 
nuclear protein localization-4 (Npl4) was first identified in a yeast screen for 
temperature-sensitive mutants that accumulate nuclear proteins in the cytoplasm 
upon shift to the semi-permissive temperature (DeHoratius and Silver, 1996). Npl4 
binds to the ubiquitin fusion degradation 1 protein (Ufd1) in a 1:1 stoichiometry and 
exists either as heterodimer or bound to p97 (Meyer et al., 2000) (Bruderer et al., 
2004). It was shown that Ufd1 is unstable in the absence of Npl4, and that the 
heterodimer Ufd1-Npl4 is the only essential cofactor in yeast (DeHoratius and Silver, 
1996) (Johnson et al., 1995). The N domain of Ufd1 is structurally similar to the N 
domain of p97 and contains binding-sites for both mono- and polyubiquitin (Park et 
al., 2005). The structure of Npl4 is less understood also NMR studies resolved a N-
terminal UBX-L domain and a C-terminal zinc-finger (NZF), which binds to 
polyubiquitin (Isaacson et al., 2007) (Meyer et al., 2002). The interaction of Ufd1-Npl4 
with p97 has been described as bipartite with two different p97-interacting sites 
located at the UBX-L domain of Npl4 and the C-terminal BS1 motif of Ufd1 (Bruderer 
et al, 2004). Recent studies revealed different conformational states of the p97Ufd1-Npl4 
complex, in which the positions of Ufd1-Npl4 differ relative to the p97 ring, displaying 
the dynamic behaviour of the complex (Bebeacua et al., 2012). Ufd1-Npl4 directs the 
p97 function to disperse cellular functions like ERAD, activation of transcription 
factors and chromatin-associated degradation of proteins. Previous findings implicate 
the p97Ufd1-Npl4 complex in the regulation of cell cycle progression and the regulation 
of the DNA damage response, which will be described in detail in the following 
section.  
 
UBXD7 
UBXD7 belongs to the p97 co-factors that bind p97 via an UBX domain. Based on 
their domain composition UBX-proteins are divided into two major groups. The UBX-
UBA proteins contain an ubiquitin-binding ubiquitin-associated (UBA) domain and a 
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p97-binding UBX domain, whereas UBX-only proteins lack the UBA domain and the 
ability to bind ubiquitin. UBXD7 belongs together with UBXD8, FAF1, SAKS1 and 
p47 to the group of UBX-UBA containing proteins (Hurley et al., 2006). UBX-UBA 
proteins have the ability to interact with multiple E3 ligases, especially with CRL but 
also with HECT-E3 ligases (Alexandru et al., 2008). The individual UBX-UBA 
proteins thereby do not strictly interact with only one particular E3 ligase as UBXD7 
for example interacts preferentially with CUL2 and CUL4 ligases but also to lesser 
extend with CUL1 and CUL3 (den Besten et al., 2012) (Alexandru et al., 2008). 
Together with p97 and Ufd1-Npl4, UBXD7 forms a higher-ordered complex 
connected to the function of CRL E3 ligases. UBXD7 directly binds to CRL through 
its ubiquitin-interacting motif (UIM) that is located between the UBX and the UBA 
domain (Bandau et al., 2012) (den Besten et al., 2012). The UIM of UBXD7 
recognizes the ubiquitin-like small modifier NEDD8, whose dynamic conjugation to 
the CRL is required to activate the ligase activity (Saifee and Zheng, 2008). UBXD7 
links p97 to the CRL2-VHL substrate HIF1-α that is constantly degraded in normoxic 
conditions (Alexandru et al., 2008). The yeast homolog of UBXD7, Ubx5, binds to 
CRL3 and mediates together with Cdc48, Ufd1-Npl4 and Ubx4 the extraction and 
degradation of the RNA polymerase subunit 2 in response to UV-light (Verma et al., 
2011) (Schuberth and Buchberger, 2008). A recent study links UBXD7 in complex 
with p97Ufd1-Npl4 to the degradation of the CUL4A substrates DDB2 and XPC in 
response to UV light thus ensuring the proper activation of the nucleotide excision 
repair (NER) pathway (Puumalainen et al., 2014).  
 
DVC1 
DVC1, also called Spartan or C1orf124, is a multi-domain protein and contains a 
SprT-like domain at its N-terminus, a SHP box motif and a PIP box in the middle 
region and a ubiquitin-binding zinc-finger (UBZ) domain at its C-terminus (Kim et al., 
2013) (Juhasz et al., 2012) (Ghosal et al., 2012) (Centore et al., 2012). It belongs to 
the family UBZ4-type domain- containing proteins, whose UBZ4- domain is important 
for the recruitment to sites of DNA damage or stalled replication forks (Davis et al., 
2012). The first studies identified DVC1 as a protein that localizes to the sites of 
stalled replication forks after UV-light and is involved in the process of TLS. It 
interacts with ubiquitinated PCNA, also the exact mechanism remains unclear. 
Ghosal and colleagues found that DVC1 interacts with PCNA via its PIP domain and 
UBZ domain dependent on the ubiquitination of PCNA, whereas others did not find 
ubiquitination of PCNA to be important for the interaction (Ghosal et al., 2012) 
(Mosbech et al., 2012). DVC1 is expressed in human cell lines during S- and G2 
phase and is rapidly degraded upon mitotic exit (Mosbech et al., 2012). It interacts 
with Cdh1 and is ubiquitinated by the APC/CCdh1 complex in vitro suggesting that 
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APC/CCdh1 targets DVC1 for degradation. Recently, DVC1 was discovered to bind to 
p97 via its SHP box motif (Mosbech et al., 2012) (Davis et al., 2012). Both studies 
propose a model where p97 is recruited by DVC1 to the sites of DNA damage to 
promote the extraction of TLS polymerase η leading to polymerase switch after 
bypass of the DNA lesion. Unclear is, whether DVC1 binding to p97 requires Ufd1-
Npl4 as both studies reveal opposite results. DVC1 is conserved in humans and 
C.elegans, also in C.elegans it lacks the PIP domain but is conserved in its function 
to recruit p97 to sites of DNA lesions (Mosbech et al., 2012).  
 
1.3.4 p97 function in cell cycle regulation 
In addition to the above-mentioned processes, p97 also facilitates the degradation of 
chromatin-associated proteins by extracting them from the chromatin and thus 
regulate their activity. The chromatin is a large protein integration platform with 
dynamic association of proteins involved in the regulation of various processes like 
transcription, replication and mitosis. The chromatin-associated degradation of 
proteins plays an important role in maintaining genomic integrity and cellular 
homeostasis by the timely removal and degradation of proteins and protein-
complexes from the chromatin. The inactivation of p97 leads to the accumulation of 
its substrates on the chromatin and thus causes protein-induced chromatin stress, 
which negatively affects multiple DNA metabolic processes like DNA replication, DNA 
damage response and mitosis promoting genome instability (Figure 1.8). The 
following sections describe the detailed role of p97 in the single cell cycle phases and 
in response to DNA damage. 
 
G1 to S phase transition 
The p97 homolog Cdc48 was first identified in yeast in a genetic screen for cell cycle 
division mutants. Ccdc48 attaches to the ER, but upon phosphorylation it shuttles 
into the nucleus in a cell cycle dependent manner (Madeo et al., 1998). Mutations in 
the Cdc48 gene lead to a delay in the G1/S transition and to an arrest in the G2/M 
phase of the cell cycle. The yeast homolog of CDK1-cyclin ,Cdc28 – Cln, is important 
for the regulation of G1/S transition. The inhibitor Far1p, which is degraded in a 
Cdc48-dependent manner, regulates Cdc28 activity. Mutation of Cdc48 leads to the 
accumulation of ubiquitinated Far1, which than leads in turn to persisting activity of 
Cdc28. The additional mutation of Far1 can rescue the delayed G1/S phase transition 
(Fu et al., 2003). Additionally the Cdc48Ufd1-Npl4 complex controls the G1/S transition 
by the regulation of the cell wall integrity pathway in yeast. The exact mechanism of 
Cdc48 in this pathway is not completely understood also Cdc48 regulates the activity 
of Mpk1, a MAP kinase family member important for the cell wall integrity in response 
to stress (Hsieh and Chen, 2011).  
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S phase/DNA replication 
In Caenorhabditis elegans (C. elegans) the depletion of Cdc48 or Ufd1-Npl4 delays 
the progression through S phase due to the activation of the Atr1 and CHK1-
dependent intra-S phase replication checkpoint (Mouysset et al., 2008). DNA 
replication is initiated by the loading of a pre-replicative complex to each origin of 
replication (pre-RC). As mentioned before, the pre-RC consists of the origin 
recognition complex, CDC6, Cdt1 and MCM2-7. Upon phosphorylation the pre-RC 
recruits essential replication factors like MCM-10, CDC45 and the GINS complex, 
which than recruit the DNA primase and polymerases to initiate DNA synthesis. p97 
regulates Cdt1 turnover via two distinct pathways: the UV-dependent degradation of 
Cdt1 and during firing and elongation of the replication fork. After UV-induced DNA 
damage the nucleotide excision repair (NER) machinery recognizes distorted DNA 
and excises the damaged DNA strands. The arising gap is filled by DNA 
polymerases dependent on the actions of the E3 ligase complex Cul4-DDB2 and 
PCNA. Cdt1 associates with PCNA and initiates the gap filling and is removed from 
chromatin by p97Ufd1-Npl4 to prevent re-initiation (Raman et al., 2011). In C. elegans 
and Xenopus egg extracts p97 removed Cdt1 from chromatin under physiological 
conditions. Depletion of p97, Ufd1 or Npl4 leads to the stabilization of Cdt1 on the 
chromatin and subsequent stabilization of CDC45 and GINS on Cdt1 in C. elegans, 
Xenopus egg extracts and human cell lines (Franz et al., 2011). Interestingly, 
depletion of p97, Ufd1 or Npl4 did not lead to a re-replication phenotype in the 
examined model systems.  
The p97 ATPase also interacts directly with the DNA helicases Werner protein and 
HIM-6 (Blooms helicase) as well as the DNA unwinding factor (DUF), further 
promoting its crucial role in the regulation of DNA replication (Indig et al., 2004) 
(Yamada et al., 2000).  
 
Mitosis 
The p97 ATPase regulates multiple steps in the progression of mitosis. The first 
identified substrate of p97 in chromatin-associated degradation was the Aurora B 
kinase. In Xenopus egg extracts and C. elegans p97/Cdc48Ufd1-Npl4 binds to 
polyubiquitinated Aurora B and extracts it from chromatin. Removal of Aurora B 
allows the chromatin decondensation and nuclear envelope reformation during 
mitotic exit (Ramadan et al., 2007). In human cells, p97 regulates the Aurora B 
activity in early stages of mitosis (Dobrynin et al., 2011). Depletion of Ufd1 or Npl4 
causes an increase in Aurora B activity, which leads to defects in chromosome 
alignment and the miss-segregation of chromosomes. In this process, p97Ufd1-Npl4 acts 
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as negative regulator of Aurora B. In C. elegans, Cdc48 is required for the proper 
localization of the Aurora B homolog AIR-2 at the regions between homologues 
chromosomes in meiosis Ι, thus ensuring proper condensation and segregation of 
meiotic chromosomes (Sasagawa et al., 2012). Depletion of Cdc48 leads to an 
increased AIR-2 substrate phosphorylation and causes defects in chromosome 
segregation. In yeast, the p47 homolog Shp1 in complex with Cdc48 facilitates the 
nuclear localization of Glc7, which counteracts the Ipl1 (Aurora) activity. Inactivation 
of Cdc48 or Shp1 causes cell cycle arrest in metaphase due to defects in the bipolar 
attachment of the kinetochores and thus activation of the SAC (Cheng and Chen, 
2010). In Xenopus egg extracts, p97 is required for the spindle disassembly at the 
end of mitosis. Depletion of Ufd1 or Npl4 leads to defects in the spindle disassembly 
and the reformation of the interphase microtubles.  
The p97Ufd1-Npl4 complex interacts with the spindle assembly factors XMAP215, TPX2 
and Plx1 at the end of mitosis promoting their extraction from the microtubles or 
sequestration into the cytosol (Cao et al., 2003). Also in yeast, Cdc48 is required for 
the degradation of the spindle assembly factors Ase1 and Cdc5.  
In C. elegans and human cell lines, p97 together with it co-factor UBXN-2 is required 
for the regulation of Aurora A activity. In C. elegans embryos depleted of UBXN-2 
more AIR-1 (Aurora A) is recruited to the centrosomes leading to precociously 
maturation and impairment of the alignment of the mitotic spindle with the axis of 
polarity. The depletion of the human homologues of UBXN-2 p37/p47 results in 
accumulation of Aurora A at the centromeres and a delay of the centrosome 
segregation (Kress et al., 2013).  
In yeast, Cdc48 is crucial for the proper transition through mitosis by modulating the 
turnover of key proteins or the localization of the proteasome to the nucleus. In 
Schizosaccharomyces pombe, Cdc48 is required for the stabilization of Cut1, the 
yeast homolog of separase, in the metaphase to anaphase transition and thus 
ensures cell viability (Ikai and Yanagida, 2006). In Saccharomyces cerevisiae 
depletion of Cdc48 and its adaptor UBX4 leads to an arrest in mitosis and the 
accumulation of Cbl2 and Cdc20, which are normally degraded in anaphase allowing 
the mitotic exit of the cell. Cdc48-UBX4 interacts with the proteasome and is thought 
to localize it to the nucleus, where it facilitates degradation of ubiquitinated Cbl2 and 
Cdc20 (Chien and Chen, 2013).  
 
DNA damage response 
Apart from its functions in the regulation of cell cycle progression under physiological 
conditions, p97 is also important for various processes in the DNA damage response. 
During DNA replication, the cell is extremely sensitive to DNA damage induction, as 
lesions cannot be accommodated at the sites of replicative DNA polymerases. This 
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leads to a stalled progression of the DNA replication fork and to the activation of the 
DNA damage response (Lehmann, 2011). Upon activation of the DDR translesional 
DNA polymerases are recruited to the stalled replication fork. In a process called 
translesional DNA synthesis, the replicative DNA polymerases are switched to 
translesional DNA polymerases depending on the ubiquitination status of PCNA 
(Lehmann et al., 2007). The recently identified p97 co-factor, DVC1, links p97 to the 
process of TLS through the direct interaction with p97 as well as with PCNA. DVC1 
interacts with p97 through its SHP box and recruits it to stalled replication forks upon 
ubiquitination of PCNA, however the exact mechanism remains still unclear. Recent 
studies provide controversial results whether recruitment of p97 depends on the 
action of the Rad18 E3 ligase. Two groups provide evidence that DVC1 recruits 
Rad18 to the chromatin leading to enhanced ubiquitination of PCNA (Centore et al., 
2012) (Ghosal et al., 2012). Juhasz and colleagues found that DVC1 is recruited 
itself to stalled replication forks depending on Rad18 and mono-ubiquitination of 
PCNA and protects PCNA from de-ubiquitination (Juhasz et al., 2012). The second 
controversial point is the actual function of DVC1 and p97 at the sites of stalled 
replication. Two groups provide evidence that DVC1 recruits p97 to stalled replication 
forks to remove DNA polymerase η and thus allow the switch to the replicative DNA 
polymerases (Davis et al., 2012) (Mosbech et al., 2012). In contrast, Ghosal and 
colleagues show that DVC1 leads to the removal of the replicative DNA polymerase 
δ to switch to the translesional DNA polymerase η (Ghosal et al., 2012).  
As replication fork collapse can also occur due to stalled transcription at the sites of 
DNA lesions, transcription-coupled nucleotide excision repair (TC-NER) is activated 
and lesions from the transcribed DNA strand are removed (Fousteri and Mullenders, 
2008). Stalled transcription leads to the recruitment of the Cul3 E3 ligase, which 
mediates the ubiquitination the RNA polymerase ΙΙ complex and its degradation 
(Ribar et al., 2007). In yeast the Cdc48-Ubx4-Ubx5 (UBXD9 and UBXD7) complex is 
involved in the turnover of RNA polymerase ΙΙ after UV-induced DNA damage by 
targeting the RNA polymerase subunit Rbp1 for degradation (Verma et al., 2011).  
As mentioned before, unrepaired DNA damage in S phase can manifest as DNA 
double strand breaks (DSB) during cell cycle progression. Also the exposure of cells 
to ionizing radiation (IR) or DNA damaging agents like doxorubicin induces the 
formation of DSB. In recent studies, p97 was connected to the DNA damage 
response pathway after DSB induction. In response to DSB, the E3 ligase RNF8 
creates Lys48-linked ubiquitin chains, which in turn recruit the p97Ufd1-Npl4 complex to 
the sites of DNA damage. Processing of Lys48-linked substrates by p97 allows DNA 
repair proteins like 53BP1, BRAC1 and Rad51 to bind to the DNA lesions (Meerang 
et al., 2011). In undamaged chromatin L3MBTL1 can bind via its Tandem-Tudor 
domains with high affinity to methylated Lys20 of histone 4 (H4Lys20Me2). After DNA 
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damage L3MBTL1 is removed from the chromatin in a p97-dependent manner and 
53BP1 can bind to H4Lys20Me2 with its own Tudor domain (Acs et al., 2011).  
In yeast, Cdc48 together with Ufd1-Npl4 is, in addition to processing ubiquitinated 
substrates, also involved in the processing of sumoylated substrates at the site of 
DNA damage (Nie et al., 2012). The yeast variant of Ufd1 contains a sumo-
interacting motif (SIM) that binds to sumoylated conjugates and recruits the 
Cdc48Ufd1-Npl4 complex to STUbL targets. Cdc48 complex acts in concert with STUbL 
to remove stalled covalent DNA topoisomerase 1 DNA adducts. Also Rad52 is 
sumoylated in response to DNA damage. Sumoylated Rad52 interacts with Cdc48Ufd1 
leading to the removal of the Rad51/Rad52 complex from sites of DNA damage and 
thus to regulation of the Rad51 recombinase activity (Bergink et al., 2013).  
Recent results demonstrated the clinical relevance of the p97 function in the DNA 
DSB repair, as the interference with the p97 function is the basis for the pathology of 
neurodegenerative diseases. p97 binds to polyglutaminated (polyQ) disease proteins 
like Huntington, ataxin-1 and ataxin-7. It can thereby bind to the wild type form and 
mutant form of polyQ. Binding of mutant polyQ to p97 leads to impaired p97 
accumulation and interaction with related DSB repair proteins and thus to an 
increase in unrepaired DSB, which is a critical factor for the pathology of neurons 
(Fujita et al., 2013). 
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Figure 1.8: Role of p97 ATPase in the cell cycle progression.  
The circle represents the current understanding of p97 function in the regulation of cell cycle 
progression and genome stability in different model systems (Yeast, C. elegans, human). The p97 
core is extended by different adaptor proteins like Ufd1-Npl4 or p47 (blue layer). The binding of 
substrate-recruiting factors like DVC1 further directs the function of the p97 complex (orange layer). 
DVC1 directs p97Ufd1-Npl4 towards TLS whereas UBXD7-UBXD9 promotes the function in stalled 
transcription and TC-NER. The third layer (Gray) of complexity is the interaction with different E3 
ligases that ubiquitinate p97 substrates (green ring). The outer layer represents the cell cycle stages in 
which p97 plays essential role to promote cell cycle progression and maintenance of genomic stability. 
(modified from (Vaz et al., 2013)) 
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1.3.1 Aim of thesis 
Depletion of the p97Ufd1-Npl4 complex causes severe chromosome segregation defects 
in mitosis. In addition to the established function in the regulation of mitosis 
progression, p97Ufd1-Npl4 is implicated in an increasing number of interphase functions, 
including regulation of S phase progression as well as regulation and promotion of 
the DNA damage response, which makes p97 an integral component to suppress 
chromosome instability and thus maintain genomic integrity.  
In this study, we aimed at elucidating the relevance of p97Ufd1-Npl4 interphase 
functions on the manifestation of chromosome segregation defects in mitosis.  
We demonstrated that the p97Ufd1-Npl4 complex ensures proper activation of the G2/M 
checkpoint in response to DNA insults, and thus prevents the cells from entering 
mitosis with damaged DNA. Therefore, then we aimed at elucidating the molecular 
basis of the role of the p97Ufd1-Npl4 complex in the regulation of mitotic entry in 
response to DNA damage in human somatic cells. 
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2 Results 
2.1 Part Ι: The p97Ufd1-Npl4 complex ensures robustness of the G2/M 
checkpoint by facilitating CDC25A degradation 
2.1.1 Pre-mitotic defects in DNA repair lead to severe chromosome 
segregation defects in Ufd1-Npl4 depleted cells 
As mentioned above, the p97 together with its adaptor Ufd1-Npl4 has been linked to 
several aspects of the cell cycle regulation and thus maintaining genomic stability. 
Recent studies demonstrated that depletion of p97Ufd1-Npl4 leads to chromosome 
segregation errors caused by improper regulation of Aurora B kinase (Dobrynin et al. 
(2011). In addition, an increasing number of interphase functions have been 
connected to p97Ufd1-Npl4 that are important to maintain genomic stability. To 
investigate to what extent pre-mitotic functions of the p97Ufd1-Npl4 complex affect 
chromosome stability in human somatic cells, we analysed segregation errors 
caused by depletion of Ufd1-Npl4, p97 or DVC1. Segregation errors were classified 
into pre-mitotic or mitotic according to the centromere staining: misaligned 
chromosomes in metaphase and lagging chromosomes in anaphase containing a 
centromere were considered to be caused by defects in mitotic functions whereas 
chromosome fragments without centromere and anaphase bridges were considered 
to be of pre-mitotic origin (Figure 2.1 a). Depletion of CHK1 served as a positive 
control. To induce additional DNA damage, cells were treated with a dose of 3 Gy of 
ionizing irradiation (IR) or mock treated 8 h prior fixation. Fixed cells were analysed 
and confocal pictures of metaphase and anaphase cells were acquired. In 
metaphase cells without IR, depletion of Ufd1-Npl4 as well as p97 or DVC1 results in 
an increase of misaligned chromosomes over control depleted cells. Interestingly, 
p97 and DVC1 depleted cells as well as CHK1 depleted cells show a small fraction of 
cells containing chromosome fragments lacking a centromere. Also in anaphase, a 
small fraction of cells showed chromosome bridging and chromosomes lacking 
centromere, indicating a low level of pre-mitotic errors (Figure 2.1 b/c). Moreover, 
after challenging cells with additional DNA damage induced by gamma radiation, the 
fraction of pre-mitotic errors drastically increased in Ufd1-Npl4, p97 or DVC1 
depleted cells (Figure 2.1 b/c). Notably cells depleted of p97 did not enter anaphase 
after IR, indicating high levels of damage.  
Results	  
37	  
	  
 
 
Figure 2.1: Unrepaired DNA damage leads to severe chromosome segregation errors in Ufd1-
Npl4 deficient cells. 
(A) Schematic illustration of mitotic and pre-mitotic defects in metaphase and anaphase. Blue depicts 
chromatin, red dots depict centromeres. (B) Confocal micrographs of mitotic HeLa cells depleted with 
indicated siRNAs and treated with ionizing radiation (IR) or mock-treated as depicted. Cells were fixed 
8 hours after IR and stained with DAPI or CREST antibodies to visualize chromatin and centromeres, 
respectively. Luciferase siRNA served as control. Merge: DAPI – cyan, CREST – red; Scale bar: 5 µm. 
(C) Quantification of B according to classification in A. Shown are means of 3 independent 
experiments with at least 40 cells per condition. Error bars: s.d., n.d.: not determined due to low 
number of mitotic cells. Note the mitotic defects in unchallenged cells and the increase in pre-mitotic 
defects in irradiated cells.  
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To confirm that cells depleted of Ufd1-Npl4, p97 or DVC1 enter mitosis despite 
unrepaired DNA damage, HeLa cells were depleted of the mentioned proteins and 
DNA damage was induced by irradiation with 3 Gy. 8 h after IR cells were fixed and 
stained for DAPI and γ-H2AX, a marker for DNA double strand breaks. For the 
quantification of γ-H2AX foci on mitotic chromatin, confocal images of mitotic cells 
were acquired. The main population of mock irradiated mitotic cells contain less than 
five γH2AX foci per cell for all depletion conditions. Importantly however, after 
irradiation the number of cells with more than 5 foci per cell largely increased, 
meaning that cells enter mitosis despite unrepaired DNA damage (Figure 2.2 a/b). 
 
 
 
Figure 2.2: Cells depleted of Ufd1, Npl4 or DVC1 enter mitosis despite unrepaired DNA damage.  
(A) Representative images of mitotic HeLa cells depleted with the indicated siRNAs and treated with 
ionizing radiation (IR) or mock-treated as depicted. Cells were fixed 8 hours after IR and stained with 
DAPI and γH2AX. Luciferase siRNA served as control. Scale bar: 5 µm (B) Quantification of γH2AX 
foci in A. Shown are means of 3 independent experiments. n.d.: not determined due to low number of 
mitotic cells. Note that cells depleted of Ufd1, Npl4 or DVC1 enter mitosis despite DNA damage 
marked by γH2AX.  
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2.1.2 Depletion of the p97Ufd1-Npl4 complex leads to a compromised G2/M 
checkpoint 
To further analyse the observation that cells depleted of Ufd1-Npl4 enter mitosis 
despite DNA damage, we ask whether that is due to a non-functional G2/M 
checkpoint. To do so, HeLa cells were treated with siRNA against p97, Ufd1 or Npl4 
and irradiated with 3 Gy or mock irradiated. Cells were fixed 8 h after IR and stained 
for DAPI and the Ser10 phosphorylated form of histone 3 (pH3 (S10)), a marker for 
mitotic cells. Indeed, we could frequently observe pH3 (S10) positive cells after IR 
while they were virtually absent in control depleted cells (Figure 2.3 c). The increase 
of mitotic cells can result from cells arrested in mitosis after IR or due to a defect in 
the G2/M checkpoint. To confirm that the observed mitotic cells indeed entered 
mitosis after IR and were not arrested in mitosis we depleted HeLa cells of the 
mentioned proteins and treated them with 3 Gy dose of IR. CHK1 depletion served 
as a positive control. 30 min after IR, we scored cells entering mitosis by brightfield 
live cell imaging and followed them over a time period of 10 h. Indeed, cells depleted 
of Ufd1-Npl4 kept entering mitosis after irradiation whereas control-depleted cells 
efficiently arrested their cell cycle progression (Figure 2.3 a). Cells entering mitosis 
were cumulatively added up over the complete time course of imaging. Quantification 
of 3 independent experiments showed that almost 15 % of the cells depleted of Ufd1-
Npl4 enter mitosis within 10 h after IR, which is about half the amount of mitotic cells 
of the CHK1 depleted population (Figure 2.3b). However, cells depleted of p97 or the 
E3 ligase subunit βTrCP showed an intermediate effect in these experiments. 
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Figure 2.3: Ufd1-Npl4 depleted cells enter mitosis after ionizing radiation.  
(A) HeLa cells were treated with the indicated siRNAs for 48 h and irradiated with 3 Gy. 30 min after 
IR cells were imaged over a time course of 10 h. Arrowheads indicate mitotic cells. Note that Ufd1 or 
Npl4 deficient cells enter mitosis already 4 h after IR. (B) Quantification of A. The number of cells that 
enter mitosis is plotted cumulatively over a period of 10 h. The graph shows means of 3 independent 
experiments with at least 200 cells per condition. Note that 15 % of Ufd1-Npl4 depleted cells enter 
mitosis after 10 h. (C) Representative micrographs of unsynchronized HeLa cells fixed 8 h after mock 
or IR (3 Gy) treatment. Cells were fixed and stained with DAPI and pH3 (S10) antibodies. Shown are 
overlay images. Note the presence of pH3 (S10)-positive mitotic cells in Ufd1- or Npl4-depleted 
populations despite irradiation. 
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To further examine whether p97Ufd1-Npl4 is involved in the regulation of the G2/M 
checkpoint we applied a quantitative FACS approach. To do so, HeLa cells were 
depleted of Ufd1, Npl4, p97 or DVC1 and irradiated with 3 Gy or mock irradiated. To 
monitor any cell that passed the G2/M checkpoint, cells were treated with 100 ng/mL 
nocodazole (nocodazole-trap) 1 h after IR. 10 h after IR cells were fixed, stained with 
propidium iodine and pH3 (S10) and subjected to FACS analysis. We again observed 
that Ufd1-Npl4 depleted cells failed to arrest properly in the G2/M checkpoint after IR. 
About 10 % of the IR treated Ufd1-Npl4 depleted cells entered mitosis compared to 
only 2-3 % of cells in the control-depleted population. This result was then further 
confirmed by depleting Ufd1-Npl4 with additional oligonucleotides (Figure 2.4 c).  
 
 
 
Figure 2.4: Quantitative FACS analysis of cell cycle progression after irradiation confirms 
compromised G2/M checkpoint in Ufd1-Npl4, p97 or DVC1 depleted HeLa cells.  
(A) Flow cytometry data of HeLa cells stained with propidium iodide and pH3 (S10) antibodies. Cells 
were depleted with indicated siRNAs, mock-treated or irradiated as indicated and then subjected to a 
nocodazole trap for 10 h prior to analysis. Note that none of the depletions has a major effect on the 
cell cycle profile. (B) Quantification of mitotic indices based on A. Shown are means of 3 independent 
experiments with n=10.000 cells per condition. Note that depletion of p97 or Ufd1-Npl4 leads to a 
significantly reduced drop in mitotic cells after IR compared to control cells. ** p< 0.01; * p< 0.05. (C) 
Cells were treated as in A. Graph shows the quantification of mitotic indices. Note that depletion of 
Ufd1 and Npl4 with different siRNAs leads to compromised G2/M checkpoint after irradiation. 
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Likewise, also the p97 depleted populations failed to arrest in G2 phase with about 
10 % mitotic cells after IR. Interestingly, almost 20 % of cells depleted of DVC1 
entered mitosis after IR, which was comparable to the effect in the CHK1 depleted 
population (Figure 2.4 a/b). Notably, none of the depletions led to major changes in 
the cell cycle profile of otherwise untreated cells compared to control depletion 
(Figure 2.4 a). 
 
2.1.3 The p97Ufd1-Npl4 complex ensures proper degradation of CDC25A 
downstream of ubiquitination by the SCFβTrCP complex 
Upon DNA damage induction by IR, cells activate a signalling cascade to arrest in 
the cell cycle progression and prevent entering mitosis with damage DNA. The 
previous results indicate that the G2/M checkpoint is compromised in cells depleted 
of the p97Ufd1-Npl4 complex. To investigate at which step of the IR induced checkpoint 
response the function of the p97Ufd1-Npl4 complex is required, we investigated the 
phosphorylation status and total protein levels of components of the checkpoint 
response pathway. To do so, we depleted HeLa cells of Ufd1-Npl4 and treated them 
with a 6 Gy dose of IR or mock treated them. Cells were lysed 30 min after IR and 
the lysates were subjected to SDS-PAGE and Western blotting. The membranes 
were probed for different marker proteins of the DDR. Notably, none of the depletion 
conditions affected the activation of CHK1 after IR as it was phosphorylated to the full 
extends at serine 317 (pCHK1 (S317)) as well as at serine 345 (pCHK1 (S345)) 
(Figure 2.5). In parallel, full activity of CHK1 was further confirmed by increased 
levels of the phosphorylated from of CDC25C (pCDC25C (S216)) upon IR in all 
conditions (Greg Dobrynin). As expected, the CDC25A phosphatase was degraded 
in control-depleted cells within 30 min after IR whereas depletion of the SCF F-box 
protein βTrCP clearly stabilized CDC25A after IR, since the SCFβTrCP complex 
ubiquitinates CDC25A and mediates subsequent degradation of CDC25A. 
Importantly, Ufd1-Npl4 depleted cells also showed persistence of CDC25A after IR 
compared to control cells. Interestingly, the steady-state levels of CDC25A are 
increased in Ufd1-Npl4 depleted cells compared to control cells (Figure 2.5), 
indicating that the p97Ufd1-Npl4 complex is mediates CDC25A degradation 
independently of IR. 
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Figure 2.5: Depletion of Ufd1-Npl4 leads to compromised CDC25A degradation upon IR-
induced DNA damage.  
HeLa cells were depleted of the indicated proteins and treated with 6 Gy dose of IR or mock treated. 
Cells were lysed 30 min after IR and subjected for SDS-PAGE and Western blotting. Membranes were 
probed with the indicated antibodies. Note that depletion of Ufd1-Npl4 leads to increased levels of 
CDC25A in general and to persistence of CDC25A after IR compared to control depletion. 
 
To further confirm that the p97Ufd1-Npl4 complex governs CDC25A degradation we 
turned to HEK293 cells, which inducibly express HA-CDC25A and depleted p97, 
Ufd1 or Npl4 in these cells. Depletion of βTrCP served as a positive control. 
Expression of HA-CDC25A was induced 24 h after siRNA transfection. CDC25A 
degradation was induced by irradiation with 6 Gy. To block protein re-synthesis, 
50 µg/mL cyclohexamide (CHX) was added to the cells directly after IR. Cells were 
lysed at 0, 10, 20 and 30 min after IR and lysates were subjected to SDS-PAGE and 
Western blotting. As expected, depletion of βTrCP led to stabilization of HA-CDC25A 
after IR-induced DNA damage. Notably, depletion of Ufd1- Npl4 or p97 led to 
significantly increased steady state levels of HA-CDC25A compared to HA-CDC25A 
levels in control depleted cells (Figure 2.6 a/b). Additionally, in cells depleted of the 
p97Ufd1-Npl4 complex, HA-CDC25A was still present in the lysates 40 min after IR 
whereas it was virtually absent in control depleted cells (Figure 2.6 a).  
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Figure 2.6: Depletion of the p97Ufd1-Npl4 complex leads to an increase in HA-CDC25A levels and 
to persistence of HA-CDC25A after irradiation.  
(A) HEK293 cells inducibly expressing HA-CDC25A were depleted of the indicated proteins and 
subjected to 6 Gy dose of IR or mock-treated. Protein re-synthesis was inhibited by adding 50 µg/mL 
CHX to the cells. Lysates were taken at the indicated time points and subjected to SDS-PAGE and 
Western blotting. Membranes were probed with the indicated antibodies. Note that in Npl4, Ufd1 or 
p97-depleted cells, HA-CDC25A is still present in the lysates 40 min after IR. (B) Quantification of A. 
Shown is the mean value of 3 independent experiments. Note that depletion of Ufd1, Npl4 or p97 
leads to an increase of HA-CDC25A protein levels compared to control depletion. Chemiluminescence 
signal was detected with a CCD camera and the signal density was quantified using ImageJ. Signal 
density of CDC25A band in control-depleted cells was set to 1. Error bars: s.d.; ***, p< 0.001; **, 
p< 0.01; * p< 0.05.  
 
To further confirm that the p97Ufd1-Npl4 complex plays a role in the degradation of 
endogenous CDC25A, HeLa cells were treated with siRNA against Ufd1 or Npl4. 
CDC25A degradation was induced by irradiation with 6 Gy and CHX was added to 
the cells directly after IR. 0, 15 and 30 min after IR cells were lysed and subjected to 
SDS-PAGE and Western blotting. In control-depleted cells CDC25A was degraded 
within 30 min after IR, whereas depletion of βTrCP led to stabilization of CDC25A. 
Interestingly, Ufd1-Npl4 depletion resulted in increased levels of endogenous 
CDC25A at time point 0 h. Notably, CDC25A was stabilized in the slower migrating 
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form (Figure 2.7 a), indicating that CDC25A was fully phosphorylated but not further 
processed. To follow the degradation rate of CDC25A, we quantified the signal 
density of CDC25A using ImageJ. In control-depleted cells CDC25A levels were 
reduced by 50 % within 30 min after IR whereas CDC25A was fully stabilized in cells 
depleted of βTrCP. Notably, Ufd1-depleted cells showed about 75 % residual 
CDC25A 30 min after IR. However, Npl4 depletion has only a minor effect on the 
CDC25A stabilization after 30 min IR compared to control depletion. Yet, Npl4 
depletion led to increased CDC25A levels compared to control at time point 15 min 
after IR (Figure 2.7 b). 
 
 
 
Figure 2.7: The p97Ufd1-Npl4 complex ensures proper degradation of CDC25A after irradiation.  
(A) HeLa cells were transfected with the indicated siRNAs and irradiated with 6 Gy or mock irradiated. 
Additionally, cells were treated with 50 µg/mL CHX directly after IR and lysed at the indicated time 
points. Lysates were subjected to SDS-PAGE and Western blotting. Membranes were probed with the 
indicated antibodies. (B) Quantification of A. Note that depletion of Ufd1-Npl4 leads to stabilization and 
delayed degradation of CDC25A. Density of the signals on X-ray films was quantified using ImageJ 
and time point 0 h was set to 1. 
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Reconsidering the observation that also DVC1 depleted cells enter mitosis after IR, 
we ask whether DVC1 functions in the same pathway or distinct from Ufd1-Npl4. To 
do so, we depleted HeLa cells of DVC1 and βTrCP and treated cells with 6 Gy dose 
of IR or mock treated them. CHX was added directly after IR and cells were lysed 0, 
15 and 30 min after IR. Lysates were subjected to SDS-PAGE and Western blotting 
and membranes were probed with CDC25A and WEE1 antibodies. The specificity 
and efficiency of DVC1 siRNA was shown by Mosbach et al (Mosbach et al., 2012). 
Again control-depleted cells degraded CDC25A within 30 min after IR whereas it was 
strongly stabilized in the βTrCP-depleted population. Interestingly, DVC1 depleted 
cells did not show an increase in CDC25A protein levels. On the contrary, WEE1 
protein levels were strongly reduced independent of IR (Figure 2.8 a). Importantly, 
also depletion of p97 leads to reduction of WEE1 independent of IR (Figure 2.8 b).  
 
 
 
Figure 2.8: Depletion of DVC1 results in reduction of WEE1 levels independent of irradiation.  
(A) HeLa cells were depleted of DVC1 or βTrCP and treated with 6 Gy or mock irradiated. Protein 
synthesis was blocked directly after IR by adding 50 µg/mL CHX to the cells. Lysates were taken at 0, 
15 and 30 min after IR and subjected to SDS-PAGE and Western blotting. Membranes were probed 
with the indicated antibodies. Note that depletion of DVC1 leads to strong reduction of WEE1 levels 
independent of IR. (B) HeLa cells were treated with the indicated siRNAs and subjected to 10 Gy dose 
of IR. Cells were lysed 30 min after IR and subjected to SDS-PAGE and Western blotting. Membranes 
were probed with the indicated antibodies. Note that depletion or p97 or DVC1 leads to reduced 
WEE1 protein levels independent of IR.  
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In the next step we ask for the functional interactions of the p97Ufd1-Npl4 complex to 
ensure proper CDC25A degradation. Experiments carried out by Grzegorz Dobrynin 
in the laboratory, showed that p97 physically interacts with HA-CDC25A and that the 
ATPase function of p97 is required for proper degradation of HA-CDC25A (Grzegorz 
Dobrynin). Overexpression of the ATPase inactive p97 E587Q (EQ) variant led to an 
increase of p97-bound HA-CDC25A as well as an increase in its ubiquitinated 
fraction. In parallel, we ask whether p97 interacts with βTrCP as CDC25A 
degradation is mediated via its ubiquitination by the SCFβTrCP ligase complex (Figure 
2.9).  
 
 
 
Figure 2.9: Hypothesized model of the functional interaction of p97Ufd1-Npl4 complex.  
Experiments done by Greg Dobrynin in the laboratory demonstrate the physical interaction of the 
p97Ufd1-Npl4 complex with CDC25A. Additionally the ATPase function of p97 is required for proper 
degradation of CDC25A as overexpression of kinase dead p97 variant leads to an increased 
interaction with increase in the ubiquitinated fraction. In parallel we ask for a direct interaction between 
the SCF F-box protein βTrCP and the p97Ufd1-Npl4 complex. 
 
To test the possible interaction between p97 and βTrCP, HEK293 cells inducibly 
expressing p97 WT or p97 EQ variant were transfected with either GFP-βTrCP or 
GFP alone. Expression of p97 was induced 16 h before cell lysis. Cells were lysed in 
IP buffer and subjected to GFP pull down. IP samples together with 1 % inputs were 
analysed by SDS-PAGE and Western blotting. Indeed, GFP-βTrCP interacts with p97 
and its cofactors Ufd1 and Npl4. Notably, the interaction was increased in the p97EQ 
background (Figure 2.10).  
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Figure 2.10: The p97Ufd1-Npl4 complex interacts with the SCF F-box protein βTrCP.  
(A) HEK293 cells inducibly expressing either mycSTREP tagged p97 (WT) or ATPase inactive p97 
E587Q (EQ) were transfected with GFP-βTrCP or GFP empty vector. 24 h after transfection cells were 
lysed in IP buffer and lysates were subjected to GFP pull down. IP samples together with 1 % inputs 
were analysed by SDS PAGE and Western blotting. Membranes were probed with the indicated 
antibodies. Arrowheads indicate the mycSTREP p97 and endogenous p97. Note that βTrCP binds to 
the p97Ufd1-Npl4 complex and binding is increased in cells expressing the substrate trapping p97 EQ 
variant.  
 
To further confirm that the compromised G2/M checkpoint results from persistence 
CDC25A, we investigated whether inhibition of CDC25A can restore the proper 
function of the checkpoint. Therefore HeLa cells were depleted of p97, Ufd1 or Npl4 
and irradiated with 3 Gy or mock irradiated. To arrest mitotic cells, 100 µg/mL 
nocodazole was added to the cells 30 min after IR. 2 h before cell fixation, CDC25 
phosphatases were inhibited by adding 10 µM NSC663284 or vehicle alone to the 
cells. Cells were stained with propidium iodine and pH3 (S10) and the fraction of 
mitotic cells was determined by FACS analysis. Consistent with the results above, 
cells depleted of Ufd1-Npl4 entered mitosis after IR in contrast to the control-depleted 
population. However, additional inhibition of CDC25A, using the CDC25 phosphatase 
inhibitor NSC663284, fully reduced mitotic indices comparable to control-depleted 
cells (Figure 2.11 a/b). Intriguingly, while p97 depletion also caused a checkpoint 
failure, NSC663284 treatment only partially prevented cells from entering mitosis. 
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Figure 2.11: G2/M checkpoint failure in Ufd1-Npl4 depleted cells is caused by persistent 
CDC25A activity.  
(A) HeLa cells were transfected with the indicated siRNAs for 48 hours and exposed to IR (3 Gy) or 
left unchallenged. 6 h after IR, cells were treated with the CDC25-specific phosphatase inhibitor 
NSC663284 (NS(C) or vehicle alone for further 2 h before processing for flow cytometry of propidium 
iodine and pH3 (S10). (B) Quantification of A. Shown are mean values of 3 independent experiments 
with 10.000 cells per condition. Note that p97- and Ufd1-Npl4-depleted cells fail to block entry into 
mitosis, but this is restored with the CDC25 inhibitor. Error bars: s.d.; ***, p< 0.001; **, p< 0.01; * p< 
0.05.  
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2.1.4 G2/M checkpoint failure in Ufd1-Npl4 depleted cells depends on p53 
function 
As the previous experiments were performed in HeLa cells, which lack functional 
p53, we assumed that p53 proficient cells would be still able to halt cell cycle 
progression despite the lack of CDC25A inactivation after Ufd1-Npl4 depletion. To 
confirm this, we turned to the colon carcinoma cell line HCT116, which were either 
p53-proficient (p53+/+) or p53-deficient (p53-/-). HCT116 p53+/+ or HCT116 p53-/- cells 
were depleted of p97, Ufd1 or Npl4 and treated with 3 Gy ionizing radiation or mock 
treated. Cells passing the G2/M checkpoint were arrested in mitosis by adding 
100 ng/mL nocodazole 30 min after IR to the medium. Cells were fixed 8 h after IR 
and stained with propidium iodine and pH3 (S10) and the fraction of mitotic cells was 
determined by FACS. Similar to the result obtained in HeLa cells, HCT116 p53-/- cells 
depleted of Ufd1 or p97 failed to fully arrest in the G2/M checkpoint after IR. 
However, Npl4 depleted cells did not show a significant increase in the mitotic index 
after IR compared to control depletion. Importantly, moreover, HCT116 p53+/+ cells 
depleted of p97, Ufd1 or Npl4 all stopped cell cycle progression comparable to 
control-depleted cells after IR (Figure 2.12 a). To further confirm that in HCT116 cells 
the p97Ufd1-Npl4 complex indeed acts on CDC25A, HCT116 p53+/+ and p53-/- cells 
were depleted of the mentioned proteins and treated with 6 Gy irradiation or mock 
irradiated. Cells were lysed 30 min after IR and lysates subjected to SDS-PAGE and 
Western blotting. In both cell lines, CDC25A was strongly degraded within 30 min 
after IR in control depletion, whereas it was stabilized in βTrCP depletion. Again, 
depletion of p97, Ufd1 or Npl4 led to increased levels of CDC25A in untreated cells 
and persisting levels after IR compared to control depletion. In contrast, the effect 
was generally less pronounced in HCT116 p53+/+ cells (Figure 2.12 b).  
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Figure 2.12: G2/M checkpoint failure in Ufd1-Npl4 depleted cells depends on p53 deficiency.  
(A) HCT116 (p53+/+) or (p53-/-) cells were depleted of the indicated proteins and treated with 3 Gy or 
mock treated. 30 min after exposure to IR, cells were treated with 100 µg/mL nocodazole for 10 h to 
arrest any cells in mitosis that passed through the G2/M checkpoint. Cells were fixed and processed 
for flow cytometry of propidium iodine and pH3 (S10) staining. Shown are mean values of 3 
independent experiments with 10.000 cells per condition. Note that p97 or Ufd1 depletion leads to 
significantly more mitotic cells after IR compared to control-depleted cells in p53-/-, but not in p53+/+ 
cells. Error bars: s.d.; ***, p< 0.001; **, p< 0.01; * p< 0.05. (B) HCT116 (p53+/+) or (p53-/-) cells were 
depleted of the indicated proteins, and mock-treated (-) or exposed to IR (6 Gy) (+) 25 min prior to 
lysis. Lysates were subjected to immunoblot analysis with indicated antibodies. Alpha-tubulin served 
as loading control. Note that Ufd1 is again co-destabilized in Npl4-depleted cells. Also note that 
CDC25A is stabilized in p97-, Ufd1- or Npl4-depleted cells. 
 
2.1.5 Impairment of the G2/M checkpoint after irradiation is dependent on 
specific p97 adaptor proteins 
In the next step we ask whether the compromised G2/M checkpoint by p97Ufd1-Npl4 is 
specific for certain p97 adaptor proteins. Recently, the UBX domain containing p97 
adaptor proteins came into focus to target p97 complex for specific cellular functions. 
UBXD1 is implicated to function in endocytosis, whereas UBXD6 and UBXD8 are 
related to ERAD functions of p97. UBXD7 was recently implicated to connect p97 to 
ubiquitin E3 ligases ((Ritz et al., 2011); (Madsen et al., 2011); (Glinka et al., 2014); 
(Alexandru et al., 2008) (Puumalainen et al., 2014)). To evaluate to what extent UBX 
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domain containing proteins are involved in the degradation of CDC25A and thereby 
the regulation of the G2/M checkpoint, we depleted HeLa cells of the mentioned 
proteins and treated cells with 3 Gy or mock irradiated them. Cells passing the G2/M 
checkpoint were arrested by nocodazole-trap 30 min after IR. Cells were fixed 8 h 
after IR and stained with propidium iodine and pH3 (S10) and then analysed by 
FACS. None of the depletions led to major changes in otherwise untreated cells 
(Figure 2.13 a). Again, control-depleted cells failed to enter mitosis after IR. The 
same is true for UBXD6-and UBXD8-depleted cells. UBXD1-depleted cells had no 
significant effect on mitotic entry after IR compared to control depletions in these 
experiments (Figure 2.13 a/b). However and importantly, depletion of UBXD7 led to a 
significant increase of the mitotic fraction after IR compared to control depletion. 
Consistently, UBXD7 depletion also led to increased protein levels of CDC25A 
compared to control depletion (Figure 2.13 a/b/c).  
 
 
 
Figure 2.13: Impairment of the G2/M checkpoint after irradiation is dependent on specific p97 
adaptor proteins.  
(A) Flow cytometry of HeLa cells stained with propidium iodine and pH3 (S10) antibodies. Cells were 
depleted of indicated proteins, mock-treated or irradiated as indicated and then subjected to a 
nocodazole trap for 7 h prior to analysis. Arrowhead indicates UBXD1.  
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Figure legend (Figure 2.13) continued: (B) Quantification of mitotic indices based on A. Shown are 
means of 3 independent experiments with n=10.000 cells per condition. Note that only depletion of 
UBXD7 from the tested p97 UBX domain-containing adaptor proteins leads to a significant increase in 
the mitotic index after IR compared to control depletion. Error bars: s.d.; ***, p< 0.001; **, p< 0.01; * p< 
0.05. (C) HeLa cells were depleted of the indicated proteins and cell lysates subjected to SDS-PAGE 
and Western blotting. Membranes were probed with the indicated antibodies. Note that depletion of 
UBXD7 leads to increased CDC25A protein levels compared to control depletion.  
 
2.2 Part ΙΙ: The role of p97 in the DNA replication 
The primary goal of this thesis was examine the functional and molecular basics of 
p97 regulating the cell cycle progression and ensuring genomic stability. On previous 
part Ι, we have shown that p97Ufd1-Npl4 ensures proper CDC25A degradation and 
G2/M checkpoint function. Recent studies link p97 to many processes within the cell 
cycle, which regulate cell cycle progression under physiological conditions and in 
response to DNA damage. Besides regulating the progression through mitosis by 
modulating Aurora B kinase activity (Dobrynin et al. (2011), the p97Ufd1-Npl4 complex 
regulates degradation of the replication-licensing factor Cdt1 in unperturbed 
interphase cells and in response to DNA damage (Raman et al., 2011). Studies in C. 
elegans linked the function of the p97Ufd1-Npl4 complex to DNA replication and cell 
cycle progression (Mouysset et al., 2008).  
 
2.2.1 Depletion of Ufd1-Npl4 leads to a delay in recovery from replication 
stress 
In the next step, we further investigated the function of Ufd1-Npl4 in the regulation of 
cell cycle progression by performing cell synchronization experiments and checking 
for alterations in the cell cycle profiles after release from the S phase block. 
Therefore HeLa cells were depleted of Ufd1 or Npl4 and blocked in S phase by 
double thymidine block. Thymidine induces replication stress by specifically depleting 
deoxycytidine triphosphate (dCTP) from the cellular pool and thus to an early S 
phase block. 11 h after the release from the double thymidine block, cells reached G2 
phase and were treated with 3 Gy dose of IR to selectively hit G2 phase cells. 
Unsynchronized cells served as reference for the cell cycle profile and protein levels. 
Cells were collected 0, 6 and 12 h after release from second thymidine block and 
either fixed for FACS or lysed to analyse the protein levels. Fixed cells were stained 
with propidium iodine and the cell cycle profile was analysed by FACS. Control-
depleted cells peaked in G2 phase 6 h after release from second thymidine block. IR 
treatment caused the cells to arrest in G2/M phase. Depletion of Ufd1-Npl4 did not 
lead to major changes in the cell cycle profiles compared to control (Figure 2.14 b). 
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Cell lysates were subjected to SDS-PAGE, Western blotting and membranes were 
probed with antibodies against pCHK1 (S317) to check for activation of the DNA 
damage response pathway. Depletion of Ufd1-Npl4 in otherwise untreated cells did 
not lead to phosphorylation of CHK1 at S317. In control-depleted cells, which were 
lysed directly after the release from the double thymidine block, CHK1 was activated 
upon thymidine treatment and cells recovered from the induced replication stress 
within 6 h. Treatment of the cells with IR led to activation of the DNA damage 
response and phosphorylation of CHK1 at Ser317. Similarly, Ufd1-Npl4-depleted 
cells activate the DNA damage response upon thymidine-induced replication stress 
as well as after IR resulting in full phosphorylation of CHK1 at Ser317. Importantly 
however, depletion of Ufd1-Npl4 led to persistent phosphorylation of CHK1 6 h after 
release from the double thymidine block (Figure 2.14 a), indicating a delay in 
recovery.  
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Figure 2.14: Cells deficient of Ufd1-Npl4 show persistent activation of CHK1 after double 
thymidine-induced replication stress.  
(A) HeLa cells depleted of the indicated proteins were left untreated or treated with double thymidine 
block. Cells were lysed at the indicated time points after release from double thymidine block and the 
lysates were subjected to SDS-PAGE and Western blotting. 11 h after release from double thymidine 
block, cells were treated with 3 Gy ionizing radiation dose before lysis. Note that cells depleted of 
Ufd1-Npl4 show prolonged activation of CHK1 compared to control-depleted cells, which completely 
recovered from replication stress 6 h after release from the double thymidine block. (B) Cells were 
treated as in A and fixed in 4 % PFA. The DNA content of the cells was determined by propidium 
iodine staining and FACS. Note that Ufd1-Npl4 depleted cells do not show major changes in the cell 
cycle profiles compared to control-depleted cells. 
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2.2.2 Npl4 depletion causes prolonged activation of CHK1 after low dose 
aphidicolin-induced replication stress 
To further investigate the findings described in the previous section, we changed to 
low dose aphidicolin-induced replication stress. Aphidicolin inhibits the DNA 
polymerases α and δ and thereby inhibits DNA replication. Low dose of aphidicolin 
however selectively impairs the progression replication forks (Durkin and Glover, 
2007). HeLa cells were depleted of p97, Ufd1 or Npl4 and treated with 0.2 µM 
aphidicolin (APH) for 24 h or left untreated. To investigate the activation of the DNA 
damage response pathway after aphidicolin treatment, we analysed the levels of 
phosphorylated CHK1. Therefore cells were lysed 0 and 6 h after release from the 
aphidicolin-induced replication stress. Lysates were subjected to SDS-PAGE and 
Western blotting and membranes were probed with antibodies against 
phosphorylated CHK1. Control-depleted cells showed strong increase in 
phosphorylation of CHK1 at S317 as well as S345 upon APH treatment, which was 
largely reduced 6 h after release from APH. Cells depleted of p97 showed similar 
phosphorylation pattern as control cells. Interestingly, Npl4-depleted cells had slightly 
higher levels of pCHK1 (S317 and S345) and CHK1 at all time points compared to 
control. Additionally, Npl4-depleted cells showed persistent phosphorylation of CHK1 
at S317 and S345 6 h after release from APH-induced replication stress (Figure 
2.15). In contrast, Ufd1-depleted cells showed no increase in CHK1 phosphorylation 
upon treatment with APH.  
 
 
 
Figure 2.15: Depletion of Npl4 but not Ufd1 leads to persistent activation of CHK1 aphidicolin-
induced replication stress.  
U2OS cells depleted of the indicated proteins were treated with 0.2 µM aphidicolin (APH) for 24 h or 
left untreated (as). Cells were lysed after the indicated time points after release from APH. Cell lysates 
were subjected to SDS-PAGE and Western blotting. Note that only cells deficient of Npl4 show 
persistent activation of CHK1 after release from APH-induced replication stress. Note also that cells 
depleted of Ufd1 do not show activation of CHK1 at all.  
Results	  
57	  
	  
2.2.3 Depletion of DVC1, UBXD7 or Npl4 leads to accumulation of γH2AX and 
53BP1 positive foci  
Unresolved replication intermediates induced by low doses of aphidicolin are 
transferred into mitosis and converted into DNA/chromatin lesions. In the following G1 
phase these unrepaired lesions are shielded by 53BP1 against further excessive 
DNA/Chromatin degradation (Lukas et al., 2011). Therefore the increase of 53BP1 
positive foci in G1 phase cells serves as an indicator for perturbation of DNA 
replication. To further investigate the role of p97 and its cofactors in DNA replication, 
we analysed the accumulation of 53BP1 positive foci in G1 phase cells. To do so, 
U2OS cells were depleted of p97, Ufd1, Npl4, DVC1 or UBXD7 and treated with 
0.2 µM APH for 24 h or left untreated. Cells were fixed and stained with DAPI and 
53BP1 antibodies. To recognize G1 cells, cells were stained additionally for Cyclin A, 
which is expressed during S and G2 phase but is absent in G1 phase. To quantify the 
number of 53BP1 foci in G1 cells, confocal images were acquired and the number of 
53BP1 foci per cyclin A-negative cell was counted using CellProfiler. In the control-
depleted population about 15 % of the cells had more than four 53BP1 foci per G1 
cell, which did not further increase upon aphidicolin treatment. Surprisingly, the 
amount of 53BP1 positive foci in p97-depleted cells was comparable to control-
depleted cells. Ufd1 depletion led to general more cells with more than four foci per 
cell compared to control, which was however not significantly different from control. 
Importantly, depletion of Npl4, DVC1 or UBXD7 significantly accumulated 53BP1 
positive foci upon aphidicolin treatment with over 30 % of cells containing more than 
four foci per cell (Figure 2.16 a/b). However, only cells depleted of DVC1 show a 
significant increase in 53BP1 positive foci per cell upon aphidicolin treatment 
compared to DVC1-depleted cells without aphidicolin treatment.  
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Figure 2.16: Depletion of Npl4, DVC1 or UBXD7 causes an increase of replication errors which 
result in an increase of 53BP1 positive foci in G1 cells after APH treatment.  
(A) Representative images of U2OS cells depleted of the indicated proteins and treated with 0.2 µM 
APH for 24 h or left untreated. After fixation cells were stained for DAPI, cyclin A and 53BP1. As a 
marker for replication stress 53BP1 foci in G1 cells were quantified. Arrowheads indicate 53BP1 foci; 
enlarged picture of the ROI is shown in the right panel; scale bar represents 10 µm (B) Quantification 
of A. Shown are means of 3 independent experiments with at least 120 cells per condition. Note that 
depletion of Npl4, DVC1 or UBXD7 leads to a significant increase of cells with more than 4 foci/cell 
after APH treatment compared to control depletion. Error bars: s.d. ***, p< 0.001; **, p< 0.01; * p< 
0.05.  
 
Additionally to the formation of 53BP1 foci in G1 cells, unresolved replication errors 
also result in the formation of γH2AX foci on mitotic chromatin (Durkin and Glover, 
2007). To confirm our previous results with yet another marker for replication stress, 
U2OS cells were depleted of p97, Ufd1, Npl4, DVC1 or UBXD7. Cells were treated 
with 0.2 µM APH for 24 h and stained for DAPI and γH2AX. In control-depleted cells, 
we observed an increase in cells with more than four foci per cell from 20 % to 
around 40 % after aphidicolin treatment. Again, p97-depleted cells showed 
comparable result to control depletion with around 30 % of cell containing more than 
three foci per cell after aphidicolin treatment. In contrast, depletion of Npl4-Ufd1 as 
well as DVC1 or UBXD7 led to a significant increase in the cell population of cells 
containing more than four foci per cell compared to control depletion (Figure 2.17 
a/b). Additionally, depletion of Npl4, DVC1 or UBXD7 led to an increase in the mean 
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number of γH2AX foci per cell compared to control-depleted cells. On the contrary, 
depletion of p97 did not result in major changes of the mean foci number per cell 
compared to control-depleted cells.  
 
 
 
Figure 2.17: Npl4, DVC1 or UBXD7 depletion result in an increased number of γ-H2AX positive 
foci on mitotic chromatin. 
(A) Representative images of U2OS cells depleted of the indicated proteins and treated with 0,2 µM 
APH for 24 h or left untreated. After fixation cells were stained for DAPI and γ-H2AX. In magenta the 
mean γ-H2AX foci number per cell is depicted. Arrowheads indicate γ-H2AX foci on the mitotic 
chromatin. Scale bar represents 10 µm (B) Quantification of A. Note that depletion of Npl4, DVC1 or 
UBXD7 leads to a significant increase in the mean number of γ-H2AX foci per cell as well as 
increased number of cells with more than 3 foci/cell. Shown are means of 3 independent experiments 
with at least 60 cells per condition. Error bars: s.d. ***, p< 0.001; **, p< 0.01; * p< 0.05.  
 
2.3 Part ΙΙΙ: Characterization and verification of mitotic phenotypes of 
Npl4 depletion 
In the previous parts Ι and ΙΙ, we focused on the role of p97Ufd1-Npl4 complex in S 
phase and G2 phase of the cell cycle. In the third part of the thesis we focused on the 
mitotic functions of the p97Ufd1-Npl4 complex. In former studies, we and others 
described a role for p97 in regulating progression of mitosis by regulating mitotic 
kinases Aurora A and Aurora B (Kress et al., 2013). Depletion of p97Ufd1-Npl4 leads to 
missregulation of Aurora B kinase and results in chromosome congression and 
chromosome segregation defects (Dobrynin et al., 2011). Additionally, our lab 
observed the loss of BUBR1 protein on mitotic chromatin as well as on the total 
protein level upon Npl4 depletion in HeLa cells. BUBR1 is an essential member of 
Results	  
60	  
	  
the mitotic checkpoint complex, which becomes activated upon the activation of the 
spindle assembly checkpoint by unattached microtubules.  
 
2.3.1 Depletion of Npl4 leads to chromosome misalignment and chromosome 
segregation errors in mitosis 
As the loss of BUBR1 occurred not in Ufd1-depleted cells, but only after depletion of 
Npl4 with one of the tested siRNAs, we set out to verify whether the observed effect 
is specific for Npl4-depletion or due to an off-target effect of the used siRNA. In the 
first step, I reproduced the above-mentioned loss of BUBR1 on mitotic chromatin 
upon Npl4 depletion in HeLa cells. To do so, HeLa cells were depleted of Ufd1, Npl4 
or BUBR1 for 48 h, fixed and stained with BUBR1 antibodies. Consistently with 
previous results, depletion of Npl4 with siNpl4 S2, but not with siNpl4 S1, led to loss 
of BUBR1 in pro-metaphase cells (Figure 2.18).  
 
 
 
Figure 2.18: Depletion of Npl4 with siNpl4 S2 leads to loss of BUBR1 localization on pro-
metaphase chromatin.  
HeLa cells were treated with the indicated siRNAs for 48 h and fixed. Fixed cells were stained with 
DAPI and BUBR1 antibodies and analysed for BUBR1 localization in pro-metaphase cells. Note that 
depletion of Npl4 with siNpl4 S2 led to loss of BUBR1 on mitotic chromatin. Scale bar represents 5 µm 
 
However, this phenotype was only observed with one of the tested oligonucleotides 
against Npl4. To rule out a direct off-target effect of the used siRNA oligonucleotide, 
we compared the used siRNA sequences to the nucleotide sequences of Npl4 and 
BUBR1 using the BLAST tool. The used siRNA sequences showed 100 % sequence 
similarity only to the nucleotide sequence of Npl4, but no significant sequence 
similarity BUBR1 (data not shown). Therefore, we set out to verify the mitotic 
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phenotypes observed upon Npl4 depletion. To do so, we generated a HeLa cell line, 
which inducibly expresses a siRNA-resistant Npl4-3myc construct (Figure 2.19 a). 
For this purpose, we cloned rat Npl4 cDNA fused to 3myc-tag into a 
pcDNA5/FRT/TO vector and the generated pcDNA5/FRT/TO/reNpl4-3myc vector 
was transfected into HeLa Flip-in cells. The rat Npl4 cDNA does not show 100 % 
sequence similarity with the used siRNA oligonucleotides, as it has three nucleotide 
mismatches for Npl4 S2 oligonucleotide and two for Npl4 S1 oligonucleotide and is 
resistant to the used Npl4 siRNA oligonucleotides. From the transfected HeLa cells 
single cell clones were selected and tested for expression of reNpl4 upon doxycyclin 
treatment. Indeed expression of reNpl4 was induced upon treatment with 1 mg/mL 
doxycyclin (Dox) for 24 h and reNpl4 localized to the cytoplasm as well as to the 
nucleus (Figure 2.19 b). In the next step, we investigated whether reNpl4 binds to 
endogenous p97 and Ufd1. To do so, we induced expression of reNpl4 with 
doxycycline for 24 h or left the cells uninduced. Cells were lysed in IP-buffer and 
used for immunoprecipitation with anti-myc antibodies, pulling on the exogenous 
reNpl4 or anti-Ufd1 antibodies to pull out the endogenous p97Ufd1-Npl4 complex. IP 
samples together with 1% inputs (In) and 1% flowthroughs (FT) were subjected to 
SDS-PAGE and Western blotting. Membranes were probed with p97, Npl4 and Ufd1 
antibodies. Indeed, reNpl4 binds to p97 and Ufd1. Moreover, reNpl4 can be found in 
complex with endogenous Npl4 together with Ufd1 and p97 (Figure 2.19 c). In further 
experiments, we tested whether the generated reNpl4-3myc-expressing cells 
respond to siRNA transfection. For that purpose, HeLa reNpl4-3myc cells were 
treated with siRNA for 48 h and expression of reNpl4 was induced 24 h before cell 
lysis. Cell lysates were subjected to SDS-PAGE and Western blotting. Endogenous 
Npl4 protein levels were reduced upon siRNA treatment. Furthermore, the protein 
levels of reNpl4 were not affected by siRNA depletion. Again, depletion of Npl4 with 
siNpl4 S2 led to loss of BUBR1 on protein level. In addition, Ufd1 was destabilized in 
Npl4 depleted cells as previously shown (Dobrynin et al. 2011). However, cells 
expressing reNpl4 showed a slight increase in the overall levels of endogenous Npl4, 
which might result from degradation products of the overexpressed 3myc-tagged 
Npl4 variant (Figure 2.19 d).  
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Figure 2.19: Generation of an inducible HeLa cell line expressing siRNA resistant Npl4-3myc 
(reNpl4).  
(A) Schematic illustration of the generation of a HeLa cell line. (B) HeLa reNpl4-3myc cells were 
treated with 1 mg/mL doxycyclin (Dox) or left untreated. After 24 h cells were fixed and stained with 
anti-myc antibody. Note that the expression of reNpl4 is induced upon doxycyclin treatment and that 
reNpl4 localizes to the cytoplasm as well as to the nucleus. Scale bar represents 50 µm. (C) 
Expression of reNpl4 in the generated cells was induced 24 h before cell lysis. Lysates were subjected 
to immunoprecipitation with anti-myc antibodies (myc-IP) or anti-Ufd1 antibodies (Ufd1-IP). IP 
samples, together with 1 % inputs (In) and flowthroughs (FT) were analysed by SDS PAGE and 
Western blotting. Membranes were probed with the indicated antibodies. Note that reNpl4 binds to 
endogenous p97 and Ufd1. (D) HeLa reNpl4-3myc cells were treated with the indicated siRNAs for 
48 h. Expression of reNpl4 was induced 24 h before cell lysis. Cell lysates were subjected to SDS-
PAGE and Western blotting. Note that Ufd1 is co-depleted in siNpl4 treated cells and that reNpl4-
3myc levels are not affected by siNpl4 depletion.  
 
In the next step we aimed at confirming the mitotic phenotypes of Npl4 depletion in 
the generated cell line. Therefore the cells were depleted for endogenous Npl4 and 
the expression of reNpl4 was induced for 24 h. Luciferase served as control 
depletion. 48 h after siRNA transfection cells were fixed and stained for DAPI and 
BUBR1. Depletion of Npl4 with S1 oligonucleotide as well as control depletion did not 
affect the localization of BUBR1 on the mitotic chromatin. In contrast, cells depleted 
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for Npl4 using S2 oligonucleotide did not show any BUBR1 on mitotic chromatin in 
pro-metaphase cells (Figure 2.20 a). Induction of the reNpl4 protein in control- and 
Npl4-depleted cells using S1 oligonucleotide did not affect the proper localization of 
BUBR1. Interestingly, overexpression of the reNpl4 protein in cell depleted of 
endogenous Npl4 using S2 oligonucleotide did not show restoration of the BUBR1 
localization on mitotic chromatin. Instead, the BUBR1 signal in these cells is still 
strongly reduced compared to control-depleted cells (Figure 2.20 b). This indicates, 
that the observed loss of BUBR1 protein in Npl4 depleted cells is due to an off-target 
effect and not specific for Npl4 depletion. 
 
 
 
Figure 2.20: Loss of BUBR1 protein upon Npl4 depletion can not be restores by 
overexpression of reNpl4.  
(A) Representative images for siRNA depletion phenotypes in prometaphase. HeLa –reNpl4-3myc 
cells were depleted for endogenous Npl4 using the indicated siRNAs. Luciferase depletion served as 
control depletion. 24 h after siRNA transfection the expression of 3myc-tagged exogenous reNpl4 was 
induced by treatment with doxycyclin for 24 h. Afterwards, cells were fixed and stained with BUBR1 
antibodies. Scale bar represents 10 µm (B) Quantification of A. Shown are mean values of 3 
independent experiments with at least 80 cells per condition. Error bars indicate standart error, *** = p-
value < 0,001; n.s. = not significant. Note that depletion of endogenous Npl4 using S2 oligonucleotide 
leads to loss of BUBR1 protein on mitotic chromatin, which is not restored by overexpression of 
reNpl4, indicating non-specific off-taget effect of the used siRNA oligimer.  
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Depletion of Npl4 in the generated cell line resulted in an identical phenotype to the 
one that was observed previously in HeLa cells. Npl4-depleted cells showed 
misaligned chromosomes in metaphase as well as lagging chromosomes in 
anaphase. Upon induction of reNpl4 expression the chromosome misalignment was 
significantly reduced in cells treated with siNpl4 S1 oligonucleotide (Figure 2.21 a/b). 
Also chromosome segregation errors were significantly reduced upon expression of 
reNpl4. In conclusion, only the defects in chromosome alignment and segregation 
defects were considered to be specific for Npl4 depletion.  
 
 
 
Figure 2.21: Depletion of Npl4 leads to chromosome misalignment and chromosome 
segregation defects in mitosis. 
HeLa cells inducibly expressing siRNA resistant Npl4 (reNpl4) were transfected with the indicated 
siRNAs and expression of reNpl4 was induced 24 h after siRNA transfection. Cells were fixed 48 h 
after siRNA transfection and stained with DAPI. (A) Representative images for siRNA depletion 
phenotypes in metaphase and anaphase. Scale bar represents 10 µm (B) Quantification of A with at 
least 80 cells/condition. Note that the chromosome misalignment in metaphase and the chromosome 
segregation defects in anaphase can be restored by overexpression of reNpl4. Error bars indicate 
standart error, *** = p-value < 0,001, **= p-value < 0,01; *= p-value < 0,05; n.s. = not significant. 
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3 Discussion 
The Cell cycle is a tightly regulated process that governs faithful replication and 
segregation of DNA material into two daughter cells during proliferation. To ensure 
ordered and directed cell cycle progression and thus maintain genomic integrity, the 
mammalian cell cycle harbours a number of checkpoints. Among them, the G2/M 
checkpoint is activated by damaged or unreplicated DNA to prevent the cells from 
committing to mitosis, which leads to deleterious effects on chromosome 
segregation. The timely and efficient degradation of cell cycle effector proteins, 
including the CDC25A phosphatase, by the ubiquitin-proteasome pathway (UPS) is 
an essential step for robust activation of the G2/M checkpoint. CDC25A degradation 
is triggered by its phosphorylation and ubiquitination by CHK1 and βTrCP, 
respectively. However, the exact molecular mechanism by which ubiquitinated 
CDC25A is targeted for degradation is not described so far.  
The AAA – ATPase p97 is a well-known component of the UPS and is involved in a 
wide variety of cellular processes including the regulation of S phase and mitosis 
progression as well as modulating the DNA damage response by targeting 
ubiquitinated substrates for degradation. Therefore, in this study we ask whether p97 
is involved in the regulation of CDC25A degradation in human somatic cells. Our 
results confirmed, that indeed p97 together with its adaptor Ufd1-Npl4 facilities the 
degradation of CDC25A downstream of βTrCP mediated ubiquitination under 
physiological conditions and in response to DNA damage. Furthermore, we showed 
evidence that the p97 co-factor UBXD7 acts together with Ufd1-Npl4 in facilitating 
CDC25A degradation. In contrast, we identified an additional p97 co-factor, DVC1, 
involved in the regulation of the G2/M checkpoint. Interestingly, DVC1 does not act in 
the same pathway as p97Ufd1-Npl4 but through a mechanism distinct from the 
degradation of CDC25A. Moreover, we showed that depletion of p97Ufd1-Npl4 leads to 
a diminished G2/M checkpoint after IR and that this is due to the stabilization of 
CDC25A. More importantly, we demonstrated that p97Ufd1-Npl4 is essential to maintain 
genomic stability as depletion of the complex leads to mitotic entry despite the 
presence of DNA damage with an increase of mitotic aberrations and subsequent 
segregations errors.  
In the following sections I will discuss the role of p97 in the regulation of the cell cycle 
progression and the DNA damage response focussing on the regulation of the G2 to 
M transition. Furthermore, I will review the modulation of p97 function in the 
regulation of cell cycle progression by its different adaptor proteins. In the last two 
parts of the discussion, I will consider the more general role of p97 in the regulation 
of S phase and mitosis progression.  
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3.1 Part Ι: The p97Ufd1-Npl4 complex ensures robustness of the G2/M 
checkpoint 
The pre-mitotic and mitotic functions of p97 contribute to the manifestation of 
segregation errors in mitosis 
It has been previously shown that p97 is connected to multiple processes in the 
regulation of mitosis progression and, moreover, is recently implicated in a growing 
number of interphase functions, including the regulation of S phase progression and 
the modulation of the DNA damage response. Thereby the majority of p97 functions 
in the regulation of cell cycle progression are mediated by its co-factor Ufd1-Npl4. In 
mitosis, depletion of Ufd1-Npl4 causes severe chromosome misalignment and 
segregation errors, whose origins are however so far only connected to the mitotic 
functions of p97Ufd1-Npl4. Here we provide evidence that, especially after challenging 
cells with DNA damage, also the pre-mitotic interphase functions of p97Ufd1-Npl4 
contribute to the manifestation of chromosomal instability in p97Ufd1-Npl4 –depleted 
cells. Our experiments show that depletion of p97Ufd1-Npl4 primarily leads to an 
increase in segregation errors with mitotic origin, as lagging chromosomes contain a 
centromere (Figure 2.1 b/c). According to the quantification published by Burrell and 
colleagues, lagging chromosomes containing centromeres indicate mitotic 
dysfunctions resulting in the improper attachment of chromosomes (Burrell et al., 
2013). Indeed, it was shown previously that depletion of Ufd1-Npl4 leads to persisting 
Aurora B activity on the chromatin, which than results in defects in the microtubule-
kinetochore attachment and thus to defects in chromosome alignment as well as in 
chromosome segregation during mitosis (Dobrynin et al., 2011). However, 
additionally to the segregation defects caused by mitotic dysfunctions, we observed a 
small fraction of chromosome fragments lacking a centromere and the formation of 
anaphase bridges in p97Ufd1-Npl4 depleted cells, which drastically increased after 
challenging the cell with DNA damage by IR, indicating that errors from pre-mitotic 
functions were transferred into mitosis. In contrast to segregation errors with mitotic 
origin, pre-mitotic errors manifest as chromosome fragments without centromeres 
and anaphases bridges in mitosis (Burrell et al., 2013). Importantly, anaphase 
bridges are connected to DSB, as the incorrect fusion of the DNA strands manifest 
as anaphase bridge in mitosis (Geigl et al., 2008). Previous studies implicated 
p97Ufd1-Npl4 in the DNA repair in response to DSB (Meerang et al., 2011). In this 
process p97Npl4 orchestrates the response to DNA damage by extracting L3BMTL1 
from the chromatin and thus facilitates the recruitment of the DNA repair protein 
53BP1 to the sites of DNA damage (Acs et al., 2011). These studies further support 
our finding that indeed not only mitotic but also pre-mitotic functions of p97Ufd1-Npl4 
contribute to the formation of anaphase bridges and segregation defects in mitosis. 
However, anaphase bridges can also result due to errors in the microtubule 
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attachment, which finally lead to the generation of anaphase bridges (Maia et al., 
2012). As Ufd1-Npl4 depletion lead to malfunction in the proper microtubule 
attachment, anaphase bridges in unirradiated cells might rather result from the 
mitotic functions of Ufd1-Npl4 than due to pre-mitotic functions. However, we 
additionally observed an increase in the formation of γH2AX foci on the mitotic 
chromatin after IR in Ufd1-Npl4 depleted cells, indicating that cells entered mitosis 
with damaged DNA (Figure 2.2 a/b). The generation of DNA damage-induced DNA 
double strand breaks leads to subsequent phosphorylation of H2AX (γH2AX). 
Phosphorylated H2AX is than recruited to sites of DNA damage to further transduce 
the DNA damage response signal (Lobrich and Jeggo, 2007). Unrepaired DNA 
damage that is transferred into mitosis, manifest as chromosomal aberrations, 
including chromosome fragments and acentric chromosomes (Asaithamby et al., 
2011). Consistently with the above mentioned results, also the number of 
chromosomal aberrations in metaphase spreads after IR drastically increases in 
Npl4- or Ufd1-depleted cells compared to control-depleted cells, where mitotic cells 
were virtually absent (Grzegorz Dobrynin; (Riemer et al., 2014)). 
In addition to Ufd1-Npl4 another p97 cofactor, DVC1, was implicated in the regulation 
of S phase progression. DVC1 recruits p97 to the sites of DNA damage in the 
process of translesion synthesis after UV light-induced DNA damage (Davis et al., 
2012) (Mosbech et al., 2012). In contrast to Ufd1-Npl4, DVC1 is so far not implicated 
in any mitotic function. Surprisingly, in our experiments, depletion of DVC1, like Ufd1-
Npl4, caused an increase of chromosome misalignment and chromosome 
segregation errors in mitosis. Moreover importantly, after induction of DNA damage 
by IR, the number of segregation errors with pre-mitotic origin in DVC1 depleted cells 
strongly increased (Figure 2.1 b/c), indicating that indeed DNA damage resulting 
from S phase functions of DVC1 was transferred into mitosis and manifested as 
anaphase bridges and chromosome fragments. However, the exact molecular 
mechanism, how the DNA damage is transferred into mitosis in DVC1-dpeleted cells 
is yet to be identified.  
 
Depletion of p97Ufd1-Npl4 leads to an impaired G2/M checkpoint after IR. 
The presence of pre-mitotic errors in Ufd1-Npl4 depleted cells raised the question 
why the cells did not arrest in the G2/M DNA damage checkpoint, but instead entered 
mitosis despite the persistence of DNA damage. Upon induction of DNA damage the 
cell activates the ATM/ATR-dependent DNA damage response leading to 
subsequent cell cycle arrest (Lobrich and Jeggo, 2007). In our previous experiments 
with fixed cells and chromosomal spreads, we found evidence that cells depleted of 
Ufd1-Npl4 did not arrest in the cell cycle progression upon IR treatment. In live-cell 
imaging experiments, we showed that cells depleted of Ufd1-Npl4 indeed entered 
	   Discussion	  
68	  
	  
mitosis after IR, indicating that the G2/M checkpoint activating is impaired in these 
cells (Figure 2.3 a/b). Furthermore, quantitative FACS analysis confirmed our 
previous observation that cells depleted of Ufd1-Npl4 or DVC1 entered mitosis after 
IR, providing evidence for an impaired G2/M checkpoint activation in response to IR 
in these cells (Figure 2.4 a/b). Interestingly, cells depleted of p97 as well as cells 
depleted of the SCF E3 ligase F-box protein βTrCP showed only a small number of 
cells entering mitosis after IR in the live-cell imaging analysis. This can result from 
pleiotropic effects, as both proteins are implicated in the regulation of a wide variety 
of cellular processes. It is known that depletion of βTrCP leads to a stabilization of 
the promoter of cell cycle progression, CDC25A (Busino et al., 2003). Interestingly, 
so far it has not been shown that depletion of βTrCP leads mitotic entry after IR, 
which might be due to the additional stabilization of WEE1, the counterpart of 
CDC25A.  
 
p97Ufd1-Npl4 facilitates the degradation of CDC25A and thus ensures robust activation 
of the G2/M checkpoint after IR. 
To cope with ionizing radiation-induced DNA damage, cells are equipped with a 
network of proteins that recognize it and subsequently lead to the activation of the 
G2/M checkpoint to prevent cell from entering mitosis with damaged DNA material 
(Lobrich and Jeggo, 2007). As described previously, in response to IR-induced DNA 
damage, the CHK1/CHK2 kinases are rapidly phosphorylated by the ATM/ATR 
kinases and become highly activated. CHK1/CHK2 further transduce the DNA 
damage signal to multiple downstream effectors, including the CDC25 phosphatases 
and WEE1 kinase. In our experiments, we showed that depletion of Ufd1-Npl4 or 
DVC1 did not lead to impaired activation of the DNA damage response, as CHK1 
was fully phosphorylated after IR (Figure 2.5). Furthermore, we showed that the 
CHK1 substrate CDC25C was phosphorylated at Ser316 in response to IR in Ufd1-
Npl4 or DVC1 depleted cells, indicating that CHK1 was active in these cells 
(Grzegorz Dobrynin, (Riemer et al., 2014)). As described earlier, another CHK1 
substrate, CDC25A, is degraded by the proteasome in response to IR-induced DNA 
damage (Melixetian et al., 2009). Importantly, in our experiments CDC25A is 
stabilized in cells depleted of Ufd1-Npl4 whereas it is fully degraded in control-
depleted cells, indicating that Ufd1-Npl4 is involved in the regulation of CDC25A 
degradation (Figure 2.5).  
Persisting CDC25A leads to the prolonged activation of CDK1-cyclinA complex and 
promotes mitotic entry (Timofeev et al., 2010). Parallel experiments carried out in our 
laboratory, showed reduced phosphorylation levels of CDK1 on Tyr15 in Ufd1-Npl4 
depleted cells after IR, indicating persistent CDC25A activity in these cells (Grzegorz 
Dobrynin). Indeed in this work, we demonstrated that the impaired G2/M checkpoint 
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in Ufd1-Npl4 depleted cells is caused by the persistence of CDC25A activity, as 
additional treatment of the cells with the CDC25 phosphatase inhibitor NSC663482 
completely restored the G2/M checkpoint after IR (Figure 2.11 a/b). 
In cyclohexamide chase experiments we confirmed, that depletion of Ufd1-Npl4 lead 
to a stabilization of exogenous HA-CDC25A as well as endogenous CDC25A under 
physiological conditions as well as after DNA damage (Figure 2.6 a/b, Figure 2.7 
a/b), indicating that Ufd1-Npl4 regulates CDC25A turnover on protein levels rather 
than CDC25A transcription rates. Consistently, parallel experiments in the laboratory, 
revealed the physical interaction of p97-Npl4 and HA-CDC25A, indicating that 
CDC25A is a direct substrate of p97Ufd1-Npl4 (Grzegorz Dobrynin, (Riemer et al., 
2014)). In line with the previous findings, we observed that expression of the 
substrate-trapping p97 EQ variant increases the amount of HA-CDC25A bound to 
p97 as well as the amount of ubiquitinated form of HA-CDC25A, further confirming a 
model, where p97Ufd1-Npl4 targets ubiquitinated CDC25A for degradation. Importantly, 
induction of DNA damage in these cells led to further accumulation of ubiquitinated 
HA-CDC25A bound to p97EQ, providing evidence for the relevance of p97 in 
facilitating CDC25A degradation after IR and thus prevent cells to commit to mitosis 
with damaged DNA (Grzegorz Dobrynin, (Riemer et al., 2014)). 
 
Does interact p97Ufd1-Npl4 with UBXD7 and SCFβTrCP to facilitate CDC25A 
degradation? 
The regulation of cell cycle progression is connected to the ubiquitination of target 
substrates by different E3 Cullin-RING-ligases complexes like the SCF- and APC/C 
E3 ligases (Vodermaier, 2004). As mentioned earlier, phosphorylated CDC25A is 
recognized by the F-box protein βTrCP and subsequently ubiquitinated by the 
SCFβTrCP E3 ligase, which than leads to it proteasomal degradation (Busino et al., 
2003). Here, we show that p97Ufd1-Npl4 physically interacts with the SCF F-box protein 
βTrCP, further confirming that p97Ufd1-Npl4 acts downstream of SCFβTrCP (Figure 2.10). 
In recent studies, p97 was linked to the SCFβTrCP complex in drosophila as well as in 
human cell lines (Zhang et al., 2013) (Li et al., 2014), which supports a more general 
model of p97Ufd1-Npl4 in targeting ubiquitinated substrates for degradation downstream 
of the SCFβTrCP E3 ligase.  
Supporting our previous result, it has been shown that the p97 co-factor UBXD7 
connects p97 to ubiquitinated substrates of CRL E3 ligases, as it interacts with p97 
as well as with multiple E3 ligases (Alexandru et al., 2008). Recent studies 
demonstrated that UBXD7 binds to NEDD8 modified cullins via its UIM domain and 
subsequently facilitates the degradation of cullin substrates (den Besten et al., 2012) 
(Bandau et al., 2012). Importantly, UBXD7 directly links p97 to the degradation of the 
cullin2-E3 ligase substrate HIF1-α (Alexandru et al., 2008) (Bandau et al., 2012). In 
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this work, we provide evidence that UBXD7 links the p97Ufd1-Npl4 complex to the 
SCFβTrCP E3 ligase in facilitating CDC25A degradation, as depletion of UBXD7 but 
not UBXD8 leads to an increase in the CDC25A protein levels (Figure 2.13 a/b/c). 
Moreover, we observed that depletion of UBXD7 but not UBXD8 lead to a significant 
increase in the mitotic fraction of cells after IR, indicating a defect in G2/M checkpoint 
activation after IR. A recent study implicated UBXD7 in the DNA damage response, 
where it acts together with p97Ufd1-Npl4 in facilitating the degradation of DDB2 and 
XPC after DNA damage induction (Puumalainen et al., 2014), further supporting the 
idea that UBXD7 acts together with p97Ufd1-Npl4 in the regulation of protein turnover in 
response to DNA damage.  
Taken together the data from this study propose a model where p97Ufd1-Npl4 together 
with UBXD7 acts downstream of SCFβTrCP in the regulation of CDC25A (Figure 3.1). 
The exact mechanism, how UBXD7 facilitates CDC25A degradation still needs to be 
clarified. One possibility is that it recognizes neddylated SCFβTrCP and recruits the 
p97Ufd1-Npl4 complex to the SCFβTrCP complex and its ubiquitinated substrate, 
CDC25A, thereby ensuring proper CDC25A degradation.  
 
 
 
Figure 3.1: Model of p97Ufd1-Npl4 complex facilitating CDC25A degradation in response to DNA 
damage.  
Upon DNA damage CHK1 is phosphorylated and thus activated by ATM/ATR kinases. Activated 
CHK1 phosphorylates CDC25A at multiple serine-residues, which primes for further phosphorylation 
of CDC25A on Ser82 by NEK11 kinase and thus creating phosphodegron for recognition by βTrCP. 
The SCFβTrCP E3 ligase ubiquitinates CDC25A and targets it for proteosomal degradation. 
Experimental data indicate that UBXD7 acts in concert with p97Ufd1-Npl4 and brings p97Ufd1-Npl4 complex 
to the SCFβTrCP complex and ubiquitinated CDC25A. p97Ufd1-Npl4 binds to ubiquitinated CDC25A and 
facilitates its degradation. 
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What is the molecular mechanism of p97 and DVC1 in the regulation of the G2/M 
checkpoint in response to DNA damage? 
As mentioned above, we showed that depletion of DVC1, like Ufd1-Npl4 depletion, 
leads to mitotic entry after IR, indicating an impaired G2/M checkpoint in these cells. 
However interestingly, DVC1, in contrast to Ufd1-Npl4, did not lead to a stabilization 
of CDC25A, indicating that DVC1 acts via a distinct mechanism in regulating the 
G2/M checkpoint after IR. Interestingly, we showed that depletion of DVC1 leads to 
strong reduction of WEE1 protein levels already under physiological conditions, 
indicating that DVC1 regulates WEE1 and not CDC25A (Figure 2.8 a/b). WEE1 is the 
counterpart of CDC25A as it modulates CDK1 with an inhibitory phosphate at Tyr15 
leading to subsequent cell cycle arrest (Lobrich and Jeggo, 2007). Moreover 
importantly, we showed that also p97-depleted cells show reduced WEE1 levels, 
whereas CDC25A is not stabilized in these cells, indicating that p97 functions in 
multiple pathways to modulate the activity of the G2/M checkpoint after IR (Figure 2.8 
b). Recently, Puumalainen and colleagues showed that the DNA damage sensor 
proteins DDB2 and XPC are degraded depending on p97Ufd1-Npl4 but not DVC1, 
further supporting a model in which different p97 co-factors mediate distinct p97 
functions in the response to DNA damage.  
The majority of studies implicate p97 in the degradation of its substrates, as depletion 
of p97 mainly leads to the stabilisation and accumulation of its target substrates. 
However, the work by Ikai and Yanagida demonstrated that cdc48/p97 is essential 
for the stabilization of cut1/separase in yeast and that depletion of p97 leads loss of 
cut1 protein (Ikai and Yanagida, 2006). Therefore it might be possible that p97DVC1 
protects WEE1 from degradation by directly binding to it, which would display an 
interesting new aspect of p97 function.  
Like CDC25A, ubiquitination by SCFβTrCP targets WEE1 for proteosomal degradation 
(Smith et al., 2007). Degradation of Wee1 is initiated by its phosphorylation by the 
Polo-like kinase 1 (PLK1) prior to ubiquitination by βTrCP and results in the 
promotion of mitotic entry after DNA damage (van Vugt et al., 2004). Therefore 
another speculation is that p97 might be involved in the degradation of Plk1 and thus 
promote G2/M arrest in response to DNA damage, as Plk1 is ubiquitinated by the 
APC/CCdh1 complex and subsequently degraded by the proteasome (Bassermann et 
al., 2008). However, first experiments done by our laboratory did not show a 
stabilization of PLK1 upon p97 depletion (Grzegorz Dobrynin). But in these 
experiments, we did not analysed specifically, whether depletion of p97 leads to 
accumulation of the higher molecular weight form of ubiquitinated PLK1, leaving the 
possibility that we therefore did not observed an accumulation of PLK1 in p97-
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depleted cells. Further experiments might clarify whether indeed depletion of p97 
causes the accumulation of PLK1 in the ubiquitinated form. 
As p97 has essential roles in many cellular processes, the destabilization of WEE1 
upon p97 depletion can also result from pleiotropic effects due to the long term 
response to reduced p97 function obtained by siRNA-mediated protein knock down. 
Therefore, further experiments using specific p97 inhibitors, which directly influence 
p97 function, are useful to analyze the effects of p97 on WEE1 protein levels.  
 
Does the G2/M checkpoint failure in Ufd1-Npl4 depleted cells depend on p53-
deficency? 
In response to DNA damage, not only the G2/M checkpoint but also the G1/S 
checkpoint is activated to prevent cell from further cell cycle progression with 
damaged DNA material and to initiate DNA damage repair. As the above mentioned 
experiments were carried out in p53-deficient HeLa cells, we suggested that cells 
with functional p53 would be able to halt cell cycle progression despite the lack of 
CDC25A inactivation in response to DNA damage in Ufd1- or Npl4-depleted cells. 
Indeed, we observed that HCT116 p53 proficient cells arrest in their cell cycle 
progression despite depletion of Ufd1-Npl4 or DVC1, indicating that these cells 
activated their residual functional DNA damage checkpoints in response to IR. In 
contrast, we observed that the p53-deficient HCT116 cells behaved similar to HeLa 
cells upon depletion of Ufd1 and DVC1 and entered mitosis after irradiation (Figure 
2.12 a/b), indicating that in 53-deficents cells the p97Ufd1-Npl4 complex is essential to 
fully activate the G2/M checkpoint in response to IR. Surprisingly, Npl4-depleted cells 
did not significantly increase in their mitotic fraction after IR compared to control-
depleted cells. This might be due to the generally less pronounced effect of Npl4 
depletion on the stabilization of CDC25A also seen in HeLa cells. 
A number of human cancer cells lack functional p53 and therefore lost the ability to 
arrest in the G1/S checkpoint after DNA damage induction. These cells largely rely on 
their G2/M checkpoint to arrest in the cell cycle progression and to repair the DNA 
damage. Therefore, additional depletion of the G2/M checkpoint leads to mitotic entry 
with damaged DNA, which causes genomic instability. As depletion of p97, DVC1 or 
Ufd1 leads to an impaired G2/M checkpoint with subsequent mitotic entry after IR, we 
suggest that these cells undergo mitotic catastrophe with subsequent cell death in or 
shortly after mitosis. Mitotic catastrophe refers to a mechanism of a delayed mitotic-
linked cell death, a sequence of events that results from premature or inappropriate 
entry of cells into mitosis that was also depicted as the main form of cell death 
induced by ionizing radiation (Vakifahmetoglu et al., 2008). In this work it was not 
fully clarified whether depletion of p97, Ufd1 or DVC1 indeed result in a mitotic 
catastrophe phenotype after IR, also the drastic increase in chromosome segregation 
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defects and chromosomal aberrations in these cells serves as indication for it (Figure 
2.1, Figure 2.2) (Riemer et al., 2014) . Further experiments should be done to clarify 
whether indeed p97-depleted cells undergo mitotic catastrophe with subsequent cell 
death after IR. 
Taken together our results provide evidence that p97Ufd1-Npl4 ensures proper 
degradation of CDC25A in response to DNA damage preventing cells to commit to 
mitosis with damaged DNA material and thus is an important component to maintain 
genomic stability in p53-deficient cells.  
 
3.2 Part ΙΙ: The role of p97 in regulation of DNA replication 
Depletion of Npl4 leads to a delay in recovery from DNA replication stress 
As previously mentioned, p97 has been implicated in different interphase processes, 
including the regulation of S phase progression. One study showed that depletion of 
p97 leads to an arrest of C. elegans embryos in S phase (Mouysset et al., 2008). 
Another study by Wójcik and colleagues demonstrated that HeLa cells arrest in S 
phase and G2/M phase with a decrease of cells in G0/G1 phase upon depletion of p97 
(Wojcik et al., 2004). In contrast, yet another study showed that HeLa cells 
accumulate in G1 after depletion of p97 (Magnaghi et al., 2013). However in our 
laboratory, we could not observe changes in the cell cycle profile after p97 depletion 
in HeLa cells (Figure 2.4 a). The discrepancy in our results and the ones observed by 
other groups, may result due to different levels of depletion efficiency and also seem 
to be cell line dependent. Supporting this idea is the recent observation that p97 
depletion had no effect on the cell cycle profile in U2OS cells, but led to an 
accumulation of cells in G2/M phase in HCT116 cells (Magnaghi et al., 2013). 
Furthermore, in our experiments depletion of Ufd1 or Npl4 also did not affect the 
progression through the cell cycle after release from double thymidine-induced S 
phase arrest. Surprisingly, HeLa cells depleted of Ufd1-Npl4 showed persistent 
activation of CHK1 after release from the double thymidine block whereas control-
depleted cells recovered from replication stress, which might be due to a defect in 
repair of the DNA damage or due to problems in the recovery from the replication 
stress (Figure 2.14 a). Using aphidicolin as yet another chemical compound to induce 
replication stress, we showed that treatment of U2OS cells with low doses of 
aphidicolin leads to phosphorylation of CHK1 at Ser315, indicating that the DNA 
damage response is activated upon aphidicolin-induced replication stress (Figure 
2.15). Low doses of aphidicolin selectively impair the progression of replication forks 
and lead to the induction of chromosomal fragile site (CFS) breaks and subsequent 
activation of CHK1 and CHK2 (Durkin and Glover, 2007). In contrast to HeLa cells, 
only Npl4-depleted cells but not Ufd1-depleted cells show persistence activation of 
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CHK1 after release from aphidicolin (Figure 2.15), which provides evidence for a 
differential relevance of Ufd1 and Npl4 in the regulation of S phase progression in 
response to DNA damage.  
 
p97 adaptor proteins Npl4, DVC1 and UBXD7 are involved in DNA replication  
As mentioned previously, p97Ufd1-Npl4 is involved in the regulation of S phase 
progression by modulating distinct key proteins during S phase initiation and in 
response to DNA repair. Our previous results indicate a differential relevance of Ufd1 
and Npl4 in the regulation of S phase progression in response to replication stress. 
Consistently with the previous results, we observed an increase in 53BP1 foci per 
cell in Npl4-depleted cells, which we did not observe in Ufd1-depleted cells, 
indicating a higher level of replication stress in the Npl4-depleted population (Figure 
2.16). 53BP1 forms foci around DNA lesions in G1 phase cells that were generated 
by the mitotic transmission of chromosomes under replication stress (Lukas et al., 
2011). The unrepaired replication errors manifest in the following M phase as 
chromosomal aberrations, which are marked by γH2AX foci (Giunta et al., 2010). 
Using yet another assay to monitor replication stress, we confirmed that Npl4 
depletion leads to an increase in γH2AX foci per cell, which further supports our 
previous results and indicates a role for Npl4 in DNA replication (Figure 2.17). 
Interestingly, Ufd1 and not Npl4 was shown to be involved in the regulation of the 
degradation of the DNA replication-licensing factor Cdt1 in response to DNA damage 
and under physiological conditions to prevent re-licensing and the replication 
initiation with damage DNA (Raman et al., 2011). In contrast, another group found 
also Npl4 involved in this process (Franz et al., 2011), indicating that unravelling the 
functions of Ufd1 and Npl4 in the single cellular functions is still a challenging task.  
In addition to Npl4 depletion, also UBXD7 depletion caused an increase of 53BP1 
and γH2AX foci per cell, further supporting a more general role of UBXD7 acting 
together with p97Npl4 (Figure 2.16, Figure 2.17).  
However, neither Npl4 nor UBXD7 depleted cells responded to aphidicolin, as none 
of these cells showed a significant increase in 53BP1 or γH2AX foci number per cell 
in response to aphidicolin treatment. In contrast, DVC1 depletion caused a significant 
increase of γH2AX and 53BP1 upon aphidicolin treatment, indicating that DVC1 has 
an additive effect on the aphidicolin-induced replication stress and might function in 
the direct repair of aphidicolin-induced DNA damage (Figure 2.16, Figure 2.17). If 
unrepaired DNA damage is encountered during DNA replication, TLS is activated 
leading to the bypass of the DNA lesion by specialized translesional DNA 
polymerases (TLS pol) that are able to read through lesions due to their low 
replication accuracy (Franz et al., 2014). DVC1 recruits p97 to sites of DNA damage 
and thus regulates p97 function in the process of translesion DNA synthesis, 
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confirming its important role the repair of DNA damage during DNA replication (Davis 
et al., 2012) (Mosbech et al., 2012).  
Surprisingly, we did not observe a change in the 53BP1 or γH2AX foci number per 
cell in p97-depleted cells, which again might be due to pleiotropic effects of p97 
depletion. Supporting this idea is the result by Acs and colleagues that p97Ufd1-Npl4 
regulates the recruitment of 53BP1 by removing L3MBTL1 from DSB after IR (Acs et 
al., 2011). Furthermore, they showed that overexpression of a catalytically inactive, 
dominant-negative version of p97 led to a strong reduction in 53BP1 recruitment after 
IR. However, overexpression of the p97 inactive version had no influence on the 
recruitment of γH2AX to the sites of DNA damage.  
Taken together our results provide evidence that the p97 cofactors DVC1, UBXD7 
and Npl4 are implicated in DNA replication, as their depletion results in an increase 
of replication errors marked by 53BP1 or γH2AX foci. For further investigation of the 
relevance of p97 co-factors on DNA replication, additional controls, including the 
ERAD-related p97-cofactor UBXD8, need to be included into these experiments.  
 
3.3 Part ΙΙΙ: Does Npl4 depletion lead to impaired BUBR1 localization on 
mitotic chromatin? 
As mentioned earlier, p97Ufd1-Npl4 is an important component to maintain chromosome 
stability, as depletion of the complex leads to severe chromosome misalignment and 
chromosome segregation errors due to persisting Aurora B activity on the 
kinetochores (Dobrynin et al., 2011). Additionally, our laboratory discovered that 
depletion of Npl4 in HeLa cells led to a loss of BUBR1 on the chromatin as well as on 
the protein levels (Sebastian Bremer, data not shown). Upon spindle checkpoint 
activation by unattached chromosomes, BUBR1 forms a transient complex with 
BUB3 and Cdc20 leading to the final formation of the mitotic checkpoint complex 
(MCC), which consist of BUBR1-BUB3-Mad2-Cdc20. The MCC efficiently inhibits 
APC/C-mediated degradation of downstream key regulators and arrest mitotic 
progression (Musacchio and Salmon, 2007) (Yu, 2002). Depletion of BUBR1 causes 
severe chromosome misalignment (Lampson and Kapoor, 2005), similar to the 
phenotype that we observed upon Npl4-depletion. Interestingly, BUBR1 was only 
reduced in Npl4-depleted cells but not in Ufd1-depleted cells. This finding could be 
due to an unspecific off-target effect of the used Npl4 siRNA oligonucleotide or due to 
a function of Npl4 independent of Ufd1. An Ufd1-independent function of Npl4 was 
previously reported by Ballar and colleagues in the gp78 mediated ERAD that 
requires only the Cdc48–Npl4 dimer in yeast, supporting the indication of an Ufd1-
independent function in our experiments (Ballar et al., 2011). However, using a stable 
cell line inducibly expressing a rat Npl4-3myc construct (reNpl4-3myc), which is 
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resistant against the used Npl4 oligonucleotides, we did not rescue the loss of 
BUBR1 on the chromatin but we restored the chromosome misalignment and 
chromosome segregation phenotype in Npl4-depleted cells (Figure 2.20, Figure 
2.21). These findings reveal the loss of BUBR1 protein in Npl4-depleted cells as an 
off-target effect of the used oligonucleotide and do not support a role of Npl4 in 
BUBR1 protein turnover. 
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4 Material and Methods 
4.1 Cloning 
For PCR reactions the PfuUltra Fusion HS DNA polymerase (Agilent Technologies) 
was used according to manufactures instructions. For enzyme restriction and DNA 
ligation NEB enzymes were used according to manufactures recommendations. DNA 
was extracted from agarose gels with help of the QIAquick Gel Extraction Kit 
(QIAGEN). Plasmid DNA amplification was performed with the Macherey-Nagel 
NucleoBond® Xtra Maxi Kit. Transformation of plasmid DNA into E.coli XL1-blue 
cells was performed according to standard procedures.  
 
4.2 Generation of plasmid constructs 
 
3myc-tag 
For phosphorylation and annealing of complementary primers (724, 725) 1 µg of 
each primer was incubated for 1 h at 37 °C with 10 units of T4 PNK. The enzyme 
was inactivated at 95 °C for 10 min. For annealing, the primers were incubated in T4 
Ligase buffer at 74 °C for 90 min. For the generation of a pcDNA5/TO-3myc plasmid 
vector, the 3myc-tag was cloned into pcDNA5/TO (Invitrogen) vector via BamHΙ/NotΙ 
restriction sites. 
 
reNpl4-3myc 
Rat Npl4 was PCR amplified using the oligonucleotides number 704 and 706 out of a 
pIRES.puro2b.Npl4.3HA DNA vector. The amplified cDNA was cloned into the 
pcDNA5/TO-3myc vector via HindΙΙΙ restriction site. 
 
GFP - TrCP 
Flag-βTrCP pcDNA3 was obtained from Addgene (plasmid 10865) (Zhou et al., 
2000). The flag – βTrCP was cutted out from the vector via BamHI/XhoI restriction 
sites and was PCR amplified using the oligonucleotides number 1128 and 1129. The 
amplified cDNA was cloned into a pEGFP_C1 (Clontec) via the BamHI/XhoI 
restriction sites.  
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Table 4.1: Nucleotide sequences of oligonucleotides used in this work 
 
Accession	  number	  	  
 
Oligonucleotide	  sequence	  	  
	  
704 TTGACCTAAGCTTATGGCCGAGAGCATCATAATC 
706 AGTTCATAAGCTTTTAGGTCCGGGGAAGGCTGCAC 
724 GATCCGCCGCAGAACAAAAACTCATCTCAGAAGAGGAT
CTGGCAGAACAAAAACTCATCTCAGAAGAGGATCTGGC
AGAACAAAAACTCATCTCAGAAGAGGATCTGTAAGC 
725 GGCCGCTTACAGATCCTCTTCTGAGATGAGTTTTTGTT
CTGCCAGATCCTCTTCTGAGATGAGTTTTTGTTCTGCC
AGATCCTCTTCTGAGATGAGTTTTTGTTCTGCGGCG 
1128 TCAGATCTCGAGATGACCCG 
1129 TCCGGTGGATCCTTATCTGG 
 
4.3 Cell lines and maintenance 
All cells were grown and maintained in a 5 % CO2/air incubator at 37 °C. Parental 
HeLa Kyoto and U2OS cells were grown in standard D-MEM (Invitrogen) 
supplemented with 10 % FCS (PAA) and 1 % of penicillin/streptomycin (Gibco). 
Inducible HEK293 p97WT and EQ cells were generated by Julia Westermeier and 
grown in D-MEM (Invitrogen) supplemented with 10 % tetracyclin negative FCS 
(PAA), 1 % penicillin/streptomycin (Gibco), 15 µg/mL Blasticidin (Invitrogen) and 
100 µg/ml Hygromycin B (Sigma). Inducible HEK293 HA-CDC25A cells were 
generated by Grzegorz Dobrynin and grown in D-MEM (Invitrogen) supplemented 
with 10 % tetracyclin negative FCS (PAA), 1 % penicillin/streptomycin (Gibco), 
15 µg/mL Blasticidin (Invitrogen) and 100 µg/ml Hygromycin B (Sigma). HCT116 
parental and p53-/- (provided by Prof. Dr. George Illiakis, UK Essen) were grown in 
Mc Coy´s 5A standard media (c.c.pro) supplemented with 1 % L-Glutamine (Gibco), 
10 % FCS (PAA) and 1 % of penicillin/streptomycin (Gibco).  
 
4.4 Transfections 
For DNA plasmid transfections, cells were seeded and transfected using 
Lipofectamine 2000 (Invitrogen) according to the standard protocol.  
For siRNAi mediated depletion experiments, cells were grown to about 30 - 40 % 
density and transfected with siRNA oligonucleotides at final concentration of 10 nM 
for 48 h using Lipofectamine RNAiMAX (Invitrogen). All siRNAs, if not stated 
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otherwise, were purchased from Microsynth and diluted to 20 µM stock solutions. 
Non-coding or luciferase siRNA served as control depletions.   
Table 4.2: Oligonucleotide sequences used in RNAi experiments 
 
Target gene Oligo name Sequence Source 
Control siCtrl UUCUCCGAACGUGUCACGUTT	  	  
 
- 
Luciferase siLuc CGUACGCGGAAUACUUCGATT	  	  
 
Microsynth 
CHK1 siCHK1 AAGGGATAACCTCAAAATCTCTT	  	  
 
Carrassa	   et	  
al.	  2009	  
 
Npl4 siNpl4 S1 CGUGGUGGAGGAUGAGAUUTT	  	  
 
- 
Npl4 siNpl4 S2 CAGCCUCCUCCAACAAAUCTT	  	  
	  
 
Npl4 siNpl4 S4 AACAGCCUCCUCCAACAAAUCTT	   Porter et al., 
2007 
DVC1 siDVC1 S2 UCAAGUACCACCUGUAUUATT	  	  
 
Mosbech	   et	  
al.	  2012	  	  
 
Ufd1 siUfd1 S1 GGGCUACAAAGAACCCGAATT	  	  
	  
 
Ufd1 siUfd1 S2 GUGGCCACCUACUCCAAAUTT	  	  
 
 
Ufd1 siUfd1 S4 ACAAAGAACCCGAAAGACATT	  	    
UBXD1 siUBXD1 S CCAGGUGAGAAAGGAACUUTT	   	  
UBXD6 siUBXD6  GGAUGACGAGAAUUGGGUATT	   QIAgen	  
UBXD7 siUBXD7 CAGCUUGAAAGGAGUGUUUTT	   QIAgen	  
UBXD8 siUBXD8 GAAGUUAUUUCACUAAUAATT	   Suzuki	   et	   al.	  
2012	  
p97 sip97 S2 AACAGCCAUUCUCAAACAGAATT	  	  
 
Qiagen	  VCP7	  	  
- 
β- TrCP siβTrCP 1/2 GUGGAAUUUGUGGAACAUCTT	  	  
 
Busino	   et	   al.	  
2003	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4.5 Generation of stable reNpl4-3myc cell line 
To generate a cell line expressing rat Npl4, which is resistant against siNpl4 S1 and 
S2, HeLa Flip-in cells (gift from Prof. Dr. Ulrike Kutay, ETH Zurich) stably expressing 
HA-tagged Tetracyclin-repressor and H2B-mcherry were co-transfected with pOG44 
(Invitrogen) and pcDNA5/TO/reNpl4-3myc in a 9:1 ratio, respectively, with 
Lipofectamine 2000 (Invitrogen) as described above. 24 h after transfection, cells 
were cultured in selection media containing 10 % FCS (Tetracyclin free), 1 % 
Penicillin/Streptomycin, 150 µg/ml Hygromycin and 0,5 µg/ml Pyromycin until single 
cell colonies were detectable. Single cell clone were picked and cultured in 96- well 
plates.  
 
4.6 Immunofluorescence staining 
HeLa Kyoto or U2OS cells were seeded on sterile coverslips and transfected with 
siRNA. 48 h after siRNA transfection, coverslips were removed from the cell culture 
dish, washed once with PBS (Gibco) and fixed for 15 min at room temperature (RT) 
in 4 % PFA (paraformaldehyde, SIGMA). After fixation, the samples were washed 
once with PBS and permeabilized with 0.1 % Triton X-100 in PBS for 5 min at RT. 
Then, the samples were washed trice with PBS for 10 min each and blocked with 
3 % BSA (Applichem) in PBS for 30 min. After blocking, the cells were incubated with 
primary antibodies diluted in blocking solution for 1 h at RT in a wet (humid) 
chamber. Unbound primary antibodies were removed by washing the samples trice 
for 10 min with PBS. After washing, samples were incubated with secondary 
antibodies diluted in blocking solution for 30 – 60 min at RT in a wet (humid) 
chamber. Unbound secondary antibodies were removed by washing the cells trice for 
10 min with PBS. Then, the microscopy slides with cells were shortly immersed in 
dH2O to remove PBS prior to mounting on glass slides in Mowiol containing 1 µg/mL 
DAPI. 
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4.7 Antibodies and other reagents used 
Table 4.3: Antibodies used for immunofluorescence and Western blotting 
experiments. 
 
Antibody Species IF WB source 
53BP1 Rabbit 1:500 - Santa Cruz Biotech. 
BUBR1 mouse 1:1000 1:500 Millipore 
CDC25A Mouse - 1:500 Neomarker 
CHK1 Mouse - 1:500 Santa Cruz Biotech. 
CHK1	  phospho	  Ser317	  	   Rabbit - 1:500 Cell Signalling 
CHK1	  phospho	  Ser345	  	   Rabbit - 1:500 Cell Signalling 
CREST	  	   Human 1:400 - Antibodies Inc. 
Cyclin	  A1	  (6E6)	   Mouse 1:500 - Abcam 
GAPDH	   Mouse - 1:20000 Sigma- Aldrich 
GFP	  	   Mouse - 1:2000 Roche 
HA	  	   Mouse - 1:1000 Covance 
Histone	   H3	   phospho	  
Ser10	  	  
Rabbit 1:1000 - Millipore 
Myc	  (9E10)	   Mouse 1:1000 1:2000  
Npl4	  (HME18)	  	   Rabbit - 1:500 Meyer	  et	  al.,	  2000	  	  
p97	  (HME08)	  	   Rabbit - 1:2000 Meyer et al., 2000 
UBXD1	   rabbit - 1:10000 Ritz et al, 2013 
UBXD7	   Sheep - 1:500 Alexandru et al, 2008 
UBXD8	   Rabbit - 1:1000 Novus 
Ufd1	  (5E2)	  	   Mouse - 1:500 Meyer et al., 2000 
Wee1	   Rabbit - 1:500 Santa Cruz Biotech. 
α-­‐tubulin	   Mouse - 1:8000 Sigma Aldrich 
γ-­‐H2AX	  Ser139	  	   Mouse 1:5000 1:500 BioLegend 
mouse	  IgG	  Alexa	  488	  	   Goat 1:500 - Invitrogen 
Rabbit	  IgG	  Alexa	  488	   Goat 1:500 - Invitrogen 
Mouse	  IgG	  Alexa	  568	   Goat 1:500 - Invitrogen 
Rabbit	  IgG	  Alexa	  568	   Goat 1:500 - Invitrogen 
Human	  IgG	  Alexa	  594	    1:500 - Invitrogen 
mouse	  IgG	  HRP	  	   Goat - 1:10000 Bio-Rad 
Rabbit	  IgG	  HRP	   Goat - 1:10000 Bio-Rad 
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Sheep	  IgG	  HRP	       
 
4.8 Fluorescence imaging 
Live cell imaging 
HeLa Kyoto cells grown in on µ-Slide 8 well chambers (Ibidi) were transfected with 
siRNA. For image acquisition cells were cultured in minimal essential medium with 
Hank’s F12 (MEM/F12; Gibco) supplemented with 15 mM HEPES pH 7.4. Images 
were acquired every 5 min over a 10 hour time period by brightfield microscopy with 
Nikon Eclipse Ti microscope and Andor DR-328G-C01-SIL camera. During imaging 
cells were kept at 37 °C and 5 % CO2. Images were processed using ImageJ 
software (version 1.43u). 
 
Indirect immunofluorescence 
For confocal images a Yokogawa CSU-X1 unit attached to the same microscope was 
used and images were acquired with an Andor iXon X3 EMCCD camera. 
4.9 Flourescence activated cell sorting  
HeLa Kyoto or HCT116 cells were seeded and transfected with siRNA. After 48 h 
cells were exposed to 3 Gy ionizing radiation (IR). 30 min after IR 100 µg/ml 
nocodazol (Sigma) was added to the cells and 10 h after IR cells were collected and 
washed once with ice-cold PBS. Cells were pelleted by centrifugation with 1000 x g 
and fixed in 4 % PFA for 15 min RT. Cells were washed twice in PBS/0,1 %Triton X-
100 and incubated in primary antibody against pH3 (S10) for 1 h at RT. Unbound 
primary antibody was removed by washing cells trice with PBS/0,1 %Triton X-100. 
Afterwards cells were incubated with secondary antibody for 1h at RT and then 
resuspended in PBS/0,1 % Triton X-100 with 50 µg/ml RNAse A (Roche) and 
25 µg/ml Propidium iodine (Sigma). After 15 min incubation at 37 °C cells were 
analyzed by fluorescence-activated cell sorting on a BD FACS Calibur machine. The 
results were quantified by FlowJo software (Version 9.7). Cells were gated for main 
population of living cells in the forward (FSH) against sideward scatter (SSH). Cell 
doublets were gated out by FSH-area against FSH-high intensity. Cells were finally 
gated by pH3 (S10) intensity against propidium iodine (PI) intensity and mitotic index 
was defined by population with high pH3 and high PI intensity.  
 
4.10 Cell synchronization 
To synchronize cells in early S-phase cells were seeded into 6-well plate. When cells 
were about 30 % confluent 2 mM thymidine (Sigma) was added to the cells for 18 h. 
Afterwards cells were released into fresh media without thymidine for 9 h. After the 
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release 2 mM thymidine was added for 17 h. After second block cells were released 
into fresh media without thymidine and progress synchronously through G2 and M- 
phase. 
 
4.11 Cell extracts 
Collection of cell extracts was done on ice with ice-cold/4 °C cold buffers. Before lysis 
cells were washed once with PBS and collected by scraping in PBS. Collected cells 
were centrifuged with 1000 x g for 3 min. The cell pellet was resuspended in 
extraction buffer containing 150 mM KCl, 25 mM Tris pH 7.4, 5 mM MgCl2, 5 % 
glycerol, 1 % Triton X-100, 2 mM b-Mercaptoethanol (Sigma), EDTA-free Protease 
inhibitor cocktail (Roche) and Phosphatase inhibitor (Roche). For lysis cells were 
incubated in extraction buffer for 20 min on ice and centrifuged with 16.000 x g for 
15 min. Supernatant was transferred into fresh tubes, snap frozen in liquid nitrogen 
and stored at -80 °C for further experiments.  
 
Preparation of cell extracts for immunoprecipitation (IP) experiments. 
Cells were collected by scrapping in IP buffer (150 mM KCl, 50 mM Tris pH 7.4, 
5 mM MgCl2, 5 % glycerol, 1 % Triton X-100 and 2 mM b-Mercaptoethanol) 
supplemented with Complete EDTA-free protease inhibitor, PhosphoSTOP 
phosphatase inhibitor. Cells were incubated for 20 min on ice and pelleted by 
centrifugation with 16.000 x g at 4 °C for 15 min. Supernatants were transferred into 
fresh tubes and used for immunoprecipitation experiments. 
 
4.12 Immunoprecipitation 
For IP experiments cell extracts were prepared as described above and protein 
concentration was determined by using BCA assay according to manufactures 
instructions (VWR). Input samples (IN) were transferred into separate tubes. After 
addition of antibody (1 µg per 1 mg of protein) samples were incubated for 1 h at 
4 °C on a tube rotor. Dynabeads ® Protein G (Life Technologies) were washed trice 
in PBS and 20 µl beads were added to the IP samples and incubated for 1 h at 4 °C 
on the tube rotator. After incubation beads were spinned down by centrifugation with 
1000 x g for 1 min. From the supernatant flowthrough samples were transferred into 
separate tubes. IP samples were washed trice with 500 µl IP buffer. After final wash 
IP samples were resuspended in 10 µl IP buffer and 6 x Laemmli buffer was added. 
Samples were boiled at 95 °C for 5 min and subjected to SDS PAGE. 
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4.13 SDS PAGE and Western blotting 
Cell extracts were prepared as described above and samples supplemented with 6 x 
Laemmli buffer and boiled at 95 °C for 5 min. Proteins were separated by standart 
SDS PAGE protocol using SDS Running Buffer containing 200 mM Glycine, 25 mM 
Tris-HCl and 0.1 % SDS. Gels were run at a constant current of 20 mA per gel. 
Western blotting was performed by using a semi-dry Trans-Blot ® SD transfer cell 
(Bio-Rad). Proteins were blotted for 1 h on a nitrocellulose membrane (Hybond-C 
super, Amersham Biosciences®) with a constant current of 120 mA per gel using 
transfer buffer containing 1 x SDS Running Buffer supplemented with 20 % 
Methanol. After Western blotting membranes were blocked for 1 h at room 
temperature (RT) with blocking buffer containing 4 % fat free milk powder PBS, 
0.05 % Tween® 20 (Fluka) or in 1 xTBS, 0.1 % Tween® 20 (for membranes that 
were later probed with phospho-specific antibodies).  
4.14 Assays used in this study 
 
CDC25A degradation assay 
HeLa cells were seeded into 6-well plates and transfected with siRNA. 48 h after 
transfection cells were mock treated or treated with 6 Gy IR. To block protein 
synthesis cyclohexamide (CHX) was added to the cells directly after IR. Cell extracts 
were prepared as described above 15 min and 30 min after IR. Samples were 
subjected for SDS PAGE and Western blotting. The membranes were stained with 
CDC25A antibody and the signal density of the CDC25A band on the X-ray film was 
quantified by ImageJ software tool.  
 
53BP1 foci formation assay 
U2OS cells were grown on coverslips and transfected with siRNA for 48 h. Cells 
were mock or aphidicolin (0,2 µM) treated for 24 h. After treatment cells were fixed in 
4 % PFA and stained for cyclin A2 and 53BP1 as described above. For Quantification 
of 53BP1 foci number in G1 phase cells images were acquired with Nikon Eclipse Ti 
with a Yokogava CSU10 Spinning Disk Confocal microscope. 
 
γ-H2AX foci formation assay 
U2OS cells were grown on coverslips and transfected with siRNA for 48 h. Cells 
were mock or aphidicolin (0,2 µM) treated for 24 h. After treatment cells were fixed in 
4 % PFA and stained for pH3(S10) and γ-H2AX as described above. For 
quantification of γ-H2AX foci on mitotic chromatin images were acquired with Nikon 
Eclipse Ti with a Yokogava CSU10 Spinning Disk Confocal microscope. 
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Statistics 
Tests for significance were done using SigmaPlot (version 12.5) software. Results 
were tested with unpaired t-test.  
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53BP1 tumor protein p53 binding protein 1  
AAA   ATPase associated with various cellular activities  
ADP   adenosine 5’-diphosphate  
APC/C  anaphase promoting complex/cyclosome  
ATM   ataxia telangiectasia mutated  
ATP   adenosine 5’-triphosphate  
ATPase  adenosine 5’-triphosphatase  
ATR   ataxia telangiectasia and Rad3 related  
BRCA1  breast cancer 1  
Bub3  budding uninhibited by benzimidazoles 3  
Cdc20 cell division cycle 20  
Cdc25 cell division cycle 25  
Cdc48  cell division cycle protein 48  
Cdh1   cadherin 1  
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Cdt1  chromatin licensing factor 1 
CHK1/2 checkpoint kinase ½ 
CHX  cyclohexamide 
Cip/Kip CDK interacting protein/kinase inhibitory proteins 
CKI  CDK inhibitor 
CPC  chromosomal passenger complex 
CRL  cullin- RING- ligase 
DAPI  4’,6’-diamidino-2-phenylindole; DNA stain 
DDB2  DNA damage binding protein 
DDK  Dbf4 – and Drf1 – dependent kinase 
DDT  DNA damage tolerance 
DDR  DNA damage response 
DMSO dimethyl sulfoxide 
Dox  doxycycline 
DSB  double strand breaks 
DUB  deubiquitylating enzyme 
DVC1  C1orf124, Spartan 
E1  ubiquitin activating enzyme 
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E3  ubiquitin ligase 
	   Abbreviations	  	  
103	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ER  endoplasmatic reticulum 
ERAD  ER associated degradation 
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FCS  fetal calf serum 
GINS  go-Ichi-Ni-San 
H2AX  H2A histone member X 
HECT  homologous to the E6-AP carboxyl-terminus 
HIF1α  hypoxia-inducible factor 1 alpha 
IR  ionizing radiation 
L3MBTL1 L(3)mbt-like 1 
Lys  lysine 
Mad2  mitotic arrest-deficient 2 
MCC  mitotic checkpoint component 
MCM2-7 minichromosome maintainance complex 2-7 
MRN  Mre11, Rad50 and Nbs1 complex 
Nek11 NIMA (never in mitosis gene a) –related kinase 11 
Npl4  nuclear protein localization homolog 4 
ORC  origin-recognition complex 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate-buffered saline 
PCNA  proliferating nuclear antigen 
PCR  polymerase chain reaction 
PFA  paraformaldehyde 
Plk1  polo-like kinase 1 
Pol  polymerase 
RING  really interesting new gene 
RNA  ribonucleid acid 
RNAi  RNA-interference 
RNF8  ring finger protein 8 E3 ubiquitin ligase 
RNF168 ring finger protein 168 E3 ubiquitin ligase 
ROI  region of interest  
SAC  spindle assembly checkpoint 
SCF  Skp1-Cul1-F-Box 
SDS  sodium dodecyl sulfate 
Ser  serine 
siRNA  small  interfereing RNA 
Skp1  S phase kinase associated protein 1 
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SHR  seconf region of homology 
Thr  threonine 
TLS  translesion synthesis 
TrCP  beta-transducin repeat containing protein 
Tyr  tyrosine 
Ub  ubiquitin 
UBA  ubiquitin-associated domain 
UBX-L ubiquitin-like domain 
UBX  ubiquitin-regulatory X 
UBXD  UBX domain-containing protein 
UBZ  ubiquitin binding zinc finger 
Ufd1  ubiquitin fusion degradation protein 1 
UPS  ubiquitin- proteasome system 
VBM  VCP binding motif 
VIM  VCP interaction motif 
WT  wild type 
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